Alterations in the D-glucuronic acid pathway and drug metabolism by exogenous compounds: D-glucaric acid level as an indication of exposure to xenobiotics by Notten$h1947-, W.R.F.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/147644
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
ALTERATIONS IN THE D-GLUCURONIC ACID 
PATHWAY AND DRUG METABOLISM 
W EXOGENOUS COMPOUNDS 
O-glucaric 
acid 
level 
as 
indication 
of 
exposure 
to 
xenobiotics 
WILFRIED NOTTEN 

ALTERATIONS IN THE D-GLUCURONIC ACID PATHWAY AND 
DRUG METABOLISM BY EXOGENOUS COMPOUNDS 
D-glucaric acid level as an indication of exposure to xenobiotics 
Promotores: 
Prof. Dr. E.J. Ariè'ns 
Prof. Dr. СЬЛІ.А. Kuyper 
Co-referent: 
Dr. P.Th. Henderson 
ALTERATIONS IN THE D-GLUCURONIC ACID PATHWAY AND 
DRUG METABOLISM BY EXOGENOUS COMPOUNDS 
D-glucaric acid level as an indication of exposure to xenobiotics 
PROEFSCHRIFT 
TER VERKRIJGING VAN DE GRAAD VAN DOCTOR IN DE 
WISKUNDE EN NATUURWETENSCHAPPEN AAN DE KATHO-
LIEKE UNIVERSITEIT TE NIJMEGEN, OP GEZAG VAN DE 
RECTOR MAGNIFICUS PROF. MR. F.J.F.M. DUYNSTEE 
VOLGENS BESLUIT VAN HET COLLEGE VAN DECANEN 
IN HET OPENBAAR TE VERDEDIGEN OP WOENSDAG 
25 JUNI 1975 DES NAMIDDAGS TE 2.00 UUR PRECIES 
DOOR 
WILFRIDUS ROBERTUS FERDINAND NOTTEN 
GEBOREN TE HERWEN EN AERDT 
1975 
DRUK: STICHTING STUDENTENPERS NUMEGEN 
AcknowledgementB 
The author is greatly indebted to all persons who contributed to the realization of this 
study. Thanks are expressed to the staff's of the Pharmacological Department and the 
Central Animal Laboratory for technical assistance, support, valuable discussions and 
friendship. 
The author wishes to thank Mr. C.P. Nicolasen for drawing the figures and Dr. G. 
Dungworth for corrections to the english text. 
Thanks are also due to the medical staff and employees of the Shell B.V., Pernis, 
Rotterdam for their co-operation. 
The investigations were carried out in the Department of Pharmacology, University of 
Nijmegen, The Netherlands, and were supported by grants from the Praeventiefonds. 
Contents 
Introduction 
Objectives of the present investigation 
General discussion and conclusions 
Effect of disulfiram on the urinary D-glucaric acid excretion and activity 
of some enzymes involved in drug metabolism in guinea-pig 
The influence of и-hexane treatment on the glucuronic acid pathway and 
activity of some drug-metabolizing enzymes in guinea-pig 
Alteration in urinary D-glucaric acid excretion as an indication of 
exposition to xenobiotics 
Action of n-alkanes on drug-metabolizing enzymes from guinea-pig liver 
Alterations in the glucuronic acid pathway caused by various drugs 
Stimulation of the glucuronic acid pathway in isolated rat liver cells by 
phénobarbital 
Summary 
Samenvatting 
Curriculum vitae 

Introduction 
At the present time, chemical pollution of the environment has become one of 
the most acute problems of our society. The occurrence of pollutants, including 
pesticides and industrial chemicals, may not only injure both man and animals 
but may also affect vegetation and could cause a deterioration of worldwide 
climatic conditions. In view of the toxicity of these agents, which can alter phy-
siological functions in man and animals, it is of great importance that organ-
isms can degrade these foreign compounds by means of detoxicating enzymes. 
The duration and effectiveness of the action of many xenobiotics, therefore, 
depend on the activity of the detoxicating enzymes, which are predominantly 
located in the endoplasmic reticulum of liver cells. These detoxicating enzymes, 
usually called microsomal drug-metabolizing enzymes, prevent the accumula-
tion of lipid-soluble exogenous and endogenous compounds in the organism. 
Metabolism oí exogenous compounds 
The major pathways of drug metabolism are: transformation of lipid-soluble 
compounds into more polar substances by oxidation, reduction and hydrolytic 
reactions and subsequently by conjugation of these metabolites with endo-
genous substrates to hydrophilic compounds which are readily excreted in 
urine or bile (1,2). 
Key enzymes in the so-called mixed function oxidase system are cytochrome 
P450 and NADPH cytochrome P-450 reductase (3). The essential part of this 
oxidation mechanism is the transference of one atom oxygen, which is derived 
from molecular oxygen and is mediated by the terminal oxidase cytochrome 
P450, to the substrate (4). 
Conjugation reactions of xenobiotics or their metabolites are known to occur 
with several endogenous compounds such as glucuronic acid, sulfate, glycine 
and glutathione (5,6). There are many factors which influence and deter-
mine the mechanism of conjugation. Some of these are: species differences, 
concentration of the exogenous compounds, interference by other chemicals 
and enzymes and the structure of the pharmacon molecules, especially of the 
functional groups which are involved in conjugation reactions (5). 
Of all the alternatives, condensation of aglycones with glucuronic acid may 
be considered as the most important route in mammals except cat (7,8). This is 
the consequence of an inexhaustible supply of glucuronic acid as a conjugating 
agent together with the fact that glucuronidation occurs with a number of drugs 
because of the ability of glucuronic acid to react with several functional groups 
(e.g. OH. COOH, SH, NH2)(6,11). It must be stated, however, that glucuronic 
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acid reacts with aglycones only in its activated form, viz. UDPGA. The glucu-
ronyl moiety is transferred from UDPGA to the acceptor by means of the 
enzyme UDPglucuronyltransferase. 
Their localization in the membrane structure and their dependence on the 
membrane, makes it very difficult to investigate the kinetic parameters of 
most drug-metabolizing enzymes. 
Factors affecting drug metabolism 
The activity of drug-metabolizing enzymes may be altered not only by dietary, 
nutritional or hormonal changes but also by foreign chemicals ( 12-20,31). After 
chronic exposure a great variety of foreign chemicals markedly enhance the 
activities of the drug-metabolizing enzymes, by increasing the amount of these 
enzymes, which results in an increase in their own metabolism as well as the 
metabolism of other compounds (18, 32). In view of this fact it had been stated 
that enzyme induction may be a useful adaptation for protecting the organism 
against carcinogenesis or the development of other injuries caused by environ-
mental pollutants. 
Metabolism of foreign compounds generally results in the formation of much 
less toxic endproducts which can, due to their more hydrophilic nature, be 
excreted easily. However, many recent studies have indicated that very toxic 
intermediates may be produced from compounds such as carbon tetrachloride 
and paracetamol (1, 21-30). Enzyme inducers of course raise the possibility of 
impairments by accelerating the synthesis of these toxic metabolites (24, 26, 
32-36). 
Since various normal body constituents are also metabolized by the same 
enzymes as pharmaca, stimulation of these enzymes accordingly results in an 
enhanced elimination of these compounds (reviewed by Conney (19)). Well-
known examples are the enhanced hydroxylation of steroids (39,40) and the in-
crease in bilirubine glucuronidation (37, 38). A large variety of xenobiotics are 
also capable of stimulating carbohydrate metabolism via the D-glucuronic acid 
pathway. This occurs by a sequence of biochemical processes in which hexose is 
transformed via UDPG, UDPGA and D-glucuronic acid to L-ascorbic acid, 
D-glucaric acid and L-xylulose respectively (41-44). 
Exposition tests 
In relation to the occurrence of intoxication phenomena it is, in view of pre-
ventive measures, of great importance to have several test methods at ones dis-
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posai which allow the possibility of identifying exposure to chemical com-
pounds at subtoxic concentrations. When exposure to known agents takes 
place as generally occurs in industry, specific test methods are relevant. How-
ever. if such test methods are not available or difficult to perform and in those 
cases where exposure to a varied spectrum of unknown chemicals occurs, it is 
important that nonspecific test methods are available. Since it is known that 
numerous xenobiotics nonspecifically alter liver functions in man and animals 
at subtoxic concentrations, this observation has been the starting-point for the 
development of non-selective test methods in many investigations. In this con-
text, tests for the induction of drug-metabolizing enzymes are thought to pro-
vide good opportunities. Although enzyme induction can be easily and directly 
measured in liver preparations it is clearly unacceptable that hepatic biopsy is 
routinely applied to man. Even blood-sampling gives rise to some practical 
problems and therefore, it has to be avoided in a simple routine test. For this 
reason, methods based on the rate of plasma clearance of drugs such as phenyl-
butazone (45-47) and antipyrine (45,48,49), which indicate their rate of meta-
bolism and are thus a measure for enzyme induction, are inconvenient to per-
form. On the other hand, measurement of the urinary excretion of 6-/}-hydroxy-
cortisol (39,50), a metabolite of Cortisol whose synthesis is enhanced after treat-
ment with various xenobiotic compounds, is rather time consuming. 
Besides tests which are based on the inductive capacities of exogenous com-
pounds, other screening methods have been investigated. One example is the 
measurement of the urinary excretion of organic sulfate (51). It should be 
stated, however, that this test is not very general, since only xenobiotic com-
pounds or their metabolites which undergo conjugation with sulfate are detect-
ed with this method. 
It is known that detoxication of potential alkylating agents, which induce 
damages such as hepatic necrosis by covalent binding to macromolecules, may 
occur by conjugation with glutathione, both enzymatically and non-enzymati-
cally. The mediating enzymes in these reactions are glutathione S-transferases, 
which are located in the cytosol of the liver cell, but also of cells from other 
organs. Glutathione conjugates are further metabolized by subsequent clea-
vage of the glutamate and glycine moieties, followed by acetylation of the free 
amino group of the cysteine residue. The final product of this metabolic path-
way, a mercapturate, is subsequently excreted in the urine (5). Measurement of 
mercapturates in the urine thus may probably prove to be a valuable test which 
allows diagnosis of the presence of very toxic alkylating compounds in the body. 
D-Glucarie acid test 
As has already been mentioned above, many xenobiotic compounds are capable 
of stimulating the glucuronic acid pathway in man and animals. In 1940, 
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Longenecker and his coworkers (52) demonstrated that barbiturates and pyra-
zolone derivatives, administered to rats, enhance the urinary excretion of 
L-ascorbic acid. During the past decade this phenomenon has been observed 
with a large number of exogenous compounds (41-44). Since it became 
apparent that many agents which are capable of stimulating L-ascorbic acid 
excretion also alter the activities of the drug-metabolizing enzymes, the suppo-
sition was made that measurement of the urinary L-ascorbic acid excretion 
would provide a reliable estimate of hepatic enzyme activity (32, 43, 53). Pri-
mates and the guinea-pig, however, lack the ability to synthetize L-ascorbic acid 
because of the absence of the enzyme L-gulonolactone oxidase (54). It was first 
observed by Marsh and Reid (55) in 1963 that treatment of rats with barbital 
and chlorbutol resulted in an enhanced excretion of D-glucaric acid. Further 
studies extended this stimulative effect to various other compounds where a 
concomitant stimulation of the drug-metabolizing enzymes often occurred. 
From this observation it has been postulated that measurement of D-glucaric 
acid may serve as a reliable test for diagnosing induction of drug-metabolizing 
enzymes in man (56-60). Although the reactions subsequent to the production 
of D-glucuronic acid, as well as in the route leading to L-ascorbic acid and 
D-glucaric acid, have been fairly well established, the mechanism of the in vivo 
formation of D-glucuronic acid is still uncertain. Two pathways for the con-
version of UDPglucuronic acid to free D-glucuronic acid have been considered 
(55-58). One route refers to the hydrolyzis of UDPglucuronic acid in which a 
nucleotide pyrophosphatase (EC 3.6.1.9) and a phosphatase are involved. In an 
alternative route UDPglucuronic acid is metabolized to D-glucuronic acid 
through the successive actions of UDPglucuronyltransferase (EC 2.4.1.17) and 
/î-glucuronidase (EC 3.2.1.31). It is not exactly known at which step in the se-
quence of enzymatic processes the stimulation of the glucuronic acid pathway 
by xenobiotic compounds is initiated, although data from many investigations 
suggest that the stimulative effect occurs before or at the stage of D-glucuronic 
acid synthesis (41,42,44,65-67). 
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Objectives of the present investigation 
The present study is concerned primarily with alterations in the D-glucuronic 
acid pathway and the activities of some drug-metabolizing enzymes, which are 
stimulated by compounds foreign to the organism. Pertinent questions in this 
study, which were investigated, are listed below. 
1. Does an altered urinary D-glucaric acid excretion provide a means for devel­
oping a reliable nonspecific test for diagnosing exposure to body-foreign 
compounds? 
2. In view of the fact that a drug-induced stimulation of the hepatic drug-meta­
bolizing system is often accompanied by an enhanced synthesis of D-glucaric 
acid, the question arises as to whether the urinary excretion of D-glucaric 
acid may be considered as a measure of the drug-metabolizing capacity of 
the liver. 
3. What is the mechanism by which xenobiotic compounds stimulate the 
D-glucuronic acid pathway in the liver? 
These objectives have been examined and the results of these studies are pre­
sented in the following publications which are referred to as I-VI and are dis­
cussed in the next chapter. 
Publications 
I. Notten, W.R.F. and Henderson, P.Th. (1973), Effect of disulfiram on the urinary 
D-glucaric acid excretion and activity of some enzymes involved in drug metab­
olism in guinea pig.Archs. Int. Pharmacodyn. Ther.. 205. 199-208. 
II. Notten, W.R.F. and Henderson, P.Th. (1975), The influence of и-hexane treat­
ment on the glucuronic acid pathway and activity of some drug-metabolizing 
enzymes in guinea-pig. Biochem. Pharmac, 24,127-131. 
III. Notten, W.R.F. and Henderson, P.Th. (1975), Alteration in urinary D-glucaric 
acid excretion as an indication of exposition to xenobiotics. In: Proceedings of the 
International Symposium-Environment and Health, CEC-EPA-WHO, Paris, 
1974, in press. 
IV. Notten, W.R.F. and Henderson, P.Th. (1975), Action of n-alkanes on drug-metab­
olizing enzymes from guinea-pig liver. Biochem., Pharmac, in press. 
V. Notten, W.R.F. and Henderson, P.Th. (1975), Alterations in the glucuronic acid 
pathway caused by various drugs. Int. J. Biochem., 6,111-119. 
IV. Notten, W.R.F., Henderson, P.Th. and Kuyper, Ch.M.A. (1975) Stimulation of the 
glucuronic acid pathway in isolated rat liver cells by phénobarbital. Int. J. 
Biochem., in press. 
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General discussion and conclusions 
The D-glucaric acid test for diagnosing exposure to xenobiotic compounds 
Chronic exposure to toxic chemicals, in particular at concentrations which do 
not produce acute toxic effects, is a relevant problem both in industrial as well 
as environmental toxicology. Accumulation of these exogenous compounds in 
the body, especially in the case of lipophilic substances, may lead to serious 
intoxication phenomena. In order to avoid such unacceptable toxic damage and 
to safeguard persons against further exposure, it is necessary to develop test 
methods. In this respect nonspecific test methods may be of value since suitable 
specific methods are often lacking when exposure to a variety of unknown che-
mical compounds occurs. 
It has been found that exposure to various xenobiotic compounds leads to a 
stimulation of the D-glucuronic acid pathway, which results in an enhanced 
synthesis of D-glucaric acid. In view of this fact the urinary D-glucaric acid 
excretion may be used as an indicator of exposure to xenobiotic compounds. 
Effect of treatment with chemicals on the urinary D-glucaric acid excretion in 
animals 
During the course of the present investigation numerous compounds were 
tested for their capacity to enhance D-glucaric acid excretion. The effects of 
chronic treatment with very low, sub-toxic doses of exogenous compounds, in-
cluding some organic solvents, insecticides, fungicides and herbicides were 
studied in detail. It became evident that treatment of animals with most of these 
chemicals led to an enhanced excretion of D-glucaric acid. Phenylmercuric ace-
tate appeared to inhibit the D-glucaric acid excretion. A biphasic effect, namely 
an acutely decreased D-glucaric acid excretion which reverted to an enhanced 
urinary D-glucaric level, was observed after some days of treatment with disul-
firam (paper I). Recently, a similar inhibitory influence, which is caused by di-
sulfiram, has been observed in man (9). The results in paper I justify the conclu-
sion that an inhibition of the D-glururonolactone dehydrogenase activity, due to 
a competition between the drug and the cosubstrate NAD*, may be the reason 
for the observed initial decrease of D-glucaric acid excretion. The subsequent 
enhanced excretion was probably due to an increased inductive activity. 
D-glucuronolactone dehydrogenase mediates the conversion of D-glucurono-
lactone into D-glucaric acid. The observed equivalent Kj-values for disulfiram, 
both with D-glucuronolactone and acetaldehyde as substrate, strongly supports 
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the conclusion of Aarts and Hinnen-Bouwmans (10) that D-glucuronolactone 
dehydrogenase is identical with an aldehyde dehydrogenase. Further confirma-
tion of this hypothesis has been reported recently by Tonkes and Marsh (68) and 
Marselos and Hänninen (69). 
In most cases short-term treatment with relatively high doses of various exo-
genous compounds also caused an enhanced urinary excretion of D-glucaric 
acid. 
In view of the results obtained from the animal experiments mentioned 
above, it seems justified to assume that D-glucaric acid excretion in cases of 
both enhanced and decreased urine levels, is useful as a nonspecific parameter 
for exposure to xenobiotic compounds. 
Normal values of the urinary D-glucaric acid excretion in man 
Studies on the urinary excretion of D-glucaric acid in human subjects were 
initiated in order to establish normal values. The levels of D-glucaric acid excre-
tion per hour, both for 24 h urine collections and for urine collected overnight, 
have been compared with values related to the urinary creatinine concentration. 
The mean value for the D-glucaric acid excretion in 110 young healthy and un-
medicated male students was found to be 600 μg per hour, with no substantial 
variability during a period of one day. The observed D-glucaric acid levels in the 
urine are within the range reported by other authors (58, 70-72). 
The procedure described by Riimke and Bezemer (106) was used for deter­
mining the tolerance limits of normal values. The results justify the conclusion 
that estimates of D-glucaric acid excretion are at least equally reliable if expres­
sed in terms of creatinine excretion as compared with excretions, expressed per 
hour. Data from other laboratories have confirmed this observation (70, 73). 
Therefore, it is apparent that the performance of the D-glucaric acid test is 
ideally suitable for routine use. 
The validity of the D-glucaric acid test in man 
In recent years various studies dealing with the effects of medicaments on the 
urinary D-glucarate excretion in patients have been published (56-60, 74-78). 
A considerable number of these compounds, such as anticonvulsant drugs, 
appear to stimulate D-glucaric acid synthesis. However, the dosage levels which 
were used during drug-therapy usually greatly exceed the possible intake of 
chemicals due to environmental pollution. Little is known concerning D-gluca­
ric acid excretion in man after chronic exposure to low concentrations of che­
micals. Morgan and Roan (70)did not find a stimulation of D-glucaric acid syn­
thesis in workers exposed to pesticides in the chemical industry. On the other 
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hand, an increase in urinary D-glucarate has been observed by Hunter et al. 
(56), as well as in the present investigation (paper III), in workers with exposure 
to endrin. Further investigations are required in order to evaluate the use of the 
D-glucaric acid test in industrial and environmental hygiene. 
Influences on the D-glucuronate pathway and drag metabolism 
About 15 years ago Conney et al. (43,44, 79) observed that various compounds, 
including phenylbutazone, aminopyrine, orphenadrine, chlorcyclizine, chlor-
butol, 3-methylcholanthrene, 3,4-benzpyrene and barbiturates which were 
potent in stimulating the glucuronic acid pathway, were also capable of stimu-
lating the activity of drug-metabolizing enzymes in the liver. 
Stimulatory effects of xenobiotic compounds on the activity of drug-metab-
olizing enzymes 
According to the mode of action, the effects of exogenous compounds which 
cause alterations in the enzyme activités may be roughly divided into two cate-
gories: those effects which are related to the amount of enzyme protein and 
those effects which produce alterations in the activity of specific protein mole-
cules. 
An increase in the amount of enzyme protein may arise from either an 
enhanced "de novo" synthesis or from a reduced degradation, or both. Though 
the term "enzyme-induction" has been specifically applied to the former pro-
cess it is now simply used for describing an enhanced concentration of enzyme 
protein, resulting in an increased enzyme activity. Simultaneous with enzyme-
induction, a proliferation of the smooth endoplasmic reticulum, an increased 
number of ribosomes and an enhanced quantity of microsomal phospholipids 
in the liver may occur, as has been observed after phénobarbital treatment 
(80-84). As has already been mentioned in the introduction, numerous xeno-
biotic compounds such as drugs, pesticides, organic solvents, etc., are known to 
induce the levels of the drug-metabolizing enzymes in the liver (18, 32). 
Although many compounds with widely different molecular structures may 
increase levels of the same enzyme, enzyme-induction is not a completely non-
specific phenomenon. For example, polycyclic aromatic hydrocarbons and 
barbiturates each induce a different spectrum of microsomal drug-metabo-
lizing enzymes, including mixed function oxidases as well as conjugating en-
zymes (18,32, 85-87). Differences in inducibility between the N-demethylation 
of aminopyrine and the UDPglucuronidation of p-nitrophenol have also been 
observed for various compounds in the present study (paper III). An extensive 
review, concerning the mechanisms by which exogenous compounds exert 
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their inductive effects, has been given by Gelboin (85). 
Some characteristic examples of factors which affect the activity of separate 
enzyme molecules are: allosteric alterations, activation of inactive enzymes 
(e.g. zymogens), feedback inhibition, substrate and product inhibition and iso-
steric inhibition. With regard to the membrane bound enzymes, such as most 
of the drug-metabolizing enzymes, the membranous structure also appears to 
play an important role in regulating the activity of these enzymes (88-90). The 
dependence of the activities of drug-metabolizing enzymes on the phospho-
lipid composition of the membrane has been demonstrated by a number of 
investigators. For example, treatment of microsomes with phospholipases A 
and C, under appropriate conditions, and lysophosphatidylcholine activates 
UDPglucuronyltransferase (88-91). In the present investigation (paper IV) a 
correspondence of the UDPglucuronyltransferase activation with a release of 
phospholipids from the microsomes was found after treatment with n-alkanes. 
The observed activation of the in vivo glucuronidation, within 24 hr after 
n-hexane administration, is probably based on a similar effect (paper II). 
Phospholipases appear to inhibit the activities of the oxidative drug-meta-
bolizing enzymes (92-94). The decreased 3,4-benzpyrene hydroxylase and 
benzphetamine N-demethylase activities, due to extraction of microsomes 
with 1-butanol and acetone, are restored to control levels after addition of 
phosphatidylcholine (95). The latter compound has been shown to be required 
for the enzymatic reduction of cytochrome P-450 (96). In conclusion, n-hep-
tane (paper IV) as well as other compounds producing a type I difference spec-
trum with cytochrome P-450, accelerate the NADPH-cytochrome P-450 
reductase activity. 
D-glucaric acid: an index of drug-metabolizing enzyme activity? 
As has been previously mentioned, studies by Conney and coworkers demon-
strated for the first time the stimulatory effect of various compounds on both 
the urinary L-ascorbic acid excretion as well as the activity of drug-meta-
bolizing enzymes (43, 44, 79). Some years later, in 1963, Marsh and Reid (55) 
observed an enhanced D-glucaric acid synthesis after treatment of rats with 
chlorbutol and barbital, compounds known to be excellent inducers of the 
hepatic drug-metabolizing system. Until now, numerous studies have been 
published concerning the drug-induced parallel stimulation of the urinary 
D-glucaric acid excretion and activity of the drug-metabolizing enzymes in 
man as well as in animals (56, 58-60, 74-76, 97). A significant correlation has 
been found between D-glucaric acid excretion and plasma y-glutamyl trans-
peptidase in epileptic subjects on anticonvulsant therapy (57). The latter 
enzyme activity has been proposed to be also a useful indirect measure of 
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enzyme induction (98, 99). Roots et al. (100) have reported that in healthy 
persons, D-glucaric acid excretion, plasma y-glutamyl transpeptidase and the 
half-life of aminopyrine can be significantly correlated. A significant correla-
tion was found between the hepatic cytochrome P-450 content and the urinary 
excretion of D-glucaric acid after treatment of guinea-pigs with phénobarbital 
(101). On account of these results it has been concluded by many authors that 
the urinary excretion of D-glucaric acid may be of value as an indirect indica-
tor of the activity of microsomal drug-metabolizing enzymes in the liver (59, 
60,101) (Paper I). On the other hand, Smith and Rawlings (45), in contrast to 
Roots et al. (100), did not find any relationship between the D-glucaric acid 
excretion and the plasma /-glutamyl transpeptidase activity in a group of 
healthy and unmedicated persons. In the present study it was found that after 
long-term treatment with n-hexane, an induction of UDPglucuronyltrans-
ferase was accompanied by an increased D-glucaric acid excretion. However, 
the in vivo glucuronidation was already activated within 24 hr after the first 
dose of и-hexane without the occurrence of any measurable alterations in the 
D-glucaric acid excretion (paper II). Experiments in which guinea-pigs were 
treated chronically with various xenobiotic compounds showed that an 
enhanced D-glucaric acid excretion was not necessarily related to an induction 
of the drug-metabolizing enzymes (paper III). Short-term experiments with 
barbital, phénobarbital, nikethamide, chlorbutol, DDT and perthane revealed 
an enhanced D-glucaric acid excretion whereas no alteration in the activities 
of the drug-metabolizing enzymes could be observed (papers III and V). Dif-
ferences between the stimulatory effects of xenobiotic compounds on the drug-
metabolizing enzymes and the glucuronic acid pathway have also been 
reported by Aarts (102). Considering these results it can be stated that changes 
in the D-glucaric acid excretion do not necessarily indicate changes in the level 
of the drug-metabolizing enzyme activity of the liver. 
Mechanism of stimulation of the glucuronic acid pathway 
The stimulative action of drugs on the D-glucaric acid biosynthesis is the 
result of an increased carbohydrate metabolism via D-glucuronic acid (41-44). 
It has been mentioned above that many drugs with different chemical struc-
tures produce a stimulative action. Data, reported by various investigators, 
suggest that the stimulatory effect of xenobiotic compounds on the glucuro-
nate pathway is initiated before or at the stage of D-glucuronic acid synthesis 
(41, 65-67,103). The results in paper V demonstrate that no relationship exists 
between a stimulation of the D-glucuronic acid pathway and an enhanced in 
vivo UDPglucuronyltransferase activity. Besides its role as a drug-metaboli-
17 
zing enzyme UDPglucuronyltransferase has also been suggested to be one of 
the possibilities by which in vivo UDPGA is converted into D-glucuronic acid 
(61,62,64,65,104,105). 
The results further justify the conclusion that, at least in short-term experi-
ments, an enhanced D-glucaric acid synthesis is also independent of an induc-
tion of UDPGdehydrogenase. The latter enzyme mediates the conversion of 
UDPG into UDPGA. 
Since similar alterations were found between the synthesis of D-glucuronic 
acid, D-glucaric acid and L-ascorbic acid on the one hand and the hepatic 
UDPG and UDPGA levels on the other hand, after treatment of rats with 
xenobiotic compounds, it was concluded that the stimulation of the D-glucu-
ronic acid pathway, at least within 8 hr, is based on an enhanced availability of 
UDPG in this pathway (paper V). A similar stimulatory pattern as in vivo was 
obtained in isolated rat liver cells within 90 min after addition of phéno-
barbital. It was further observed that the enhanced UDPG level is accom-
panied by a decrease of the glycogen concentration (paper VI). 14C incorpora-
tion experiments showed that the latter effect most probably is caused by a 
decreased conversion of UDPG into glycogen. From these data it may be con-
cluded that a stimulation of the D-glucuronic acid pathway, resulting in an 
enhanced D-glucaric acid and L-ascorbic acid synthesis, is caused by an inhibi-
tion of glycogen synthesis. 
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Effect of disulfiram on the urinary D-glucaric acid excretion 
and activity of some enzymes involved in drug 
metabolism in guinea-pig 
W. R. F. NOTTEN AND P. T H . HENDERSON 
Institute of Pharmacology, Faculty of Medicine, University of Nijmegen, Nijmegen, The 
Netherlands 
Abstract—Treatment of guinea-pigs with disulfiram for 8 days resulted 
in a significant enhancement of the in vitro activities of the N-de-
methylation of aminopyrine and the glucuronyl conjugation of p-mtro-
phenol. This increase was accompanied by an induction of liver growth 
and an increase in microsomal protein content. It might be concluded 
that disulfiram has inductive properties with respect to drug metabolism. 
Disulfiram pretreatment also resulted in an enhanced urinary D-
glucaric acid excretion, approaching 200 per cent of the controls at 
the 7th day of treatment. 
In contrast a decrease in the excretion of D-glucaric acid was ob-
served in the 16-24 hr period after the beginning of the treatment. 
The same was found after loading the animals with exogenous D-glucu-
ronolactone. These effects could be explained in terms of an inhibition 
of D-glucuronolactone dehydrogenase due to competition between 
disulfiram and the cosubstrate NAD+. 
Observations indicate that disulfiram pretreatment may exert a bi-
phasic effect, an acute inhibitory activity and an induction of drug 
metabolism. 
Introduction 
Disulfiram (tetraethylthiuram disulfide) is used frequently for the treatment 
of alcoholism. Probably the drug acts by virtue of inhibiting acetaldehyde 
dehydrogenase, which catalyzes the conversion of acetaldehyde into acetic acid. 
This inhibition causes an accumulation of acetaldehyde in the organism. 
However, this is not the only effect of disulfiram. In 1951 Gairman (1) 
showed that disulfiram inhibited the metabolism of thiopental. The same has 
been found for the biotransformation of diphenylhydantoin (2), chloroform (3) 
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and aminopyrine (4). In addition, Grübner et al. (5) have found a strong increase 
in the ascorbic acid excretion in the urine of rats after pretreatment with di-
sulfiram. In many cases a stimulation of ascorbic acid synthesis may be con-
sidered as an indication for an enhanced drug metabolism (6, 7). Recently, it 
has been postulated that the urinary excretion of D-glucaric acid is a reliable 
measure of hepatic enzyme activity (8). This may be of particular importance 
for man who is unable, like the guinea-pig, to synthesize L-ascorbic acid. 
The present investigation was undertaken to study possible effects of disul-
firam on the urinary excretion of D-glucaric acid in the guinea-pig. Observed 
alterations in D-glucaric acid excretion were compared with the in vitro activities 
of some hepatic enzymes involved in drug metabolism. 
On the one hand, when disulfiram has inducing properties, one might expect 
an enhancement of the D-glucaric acid excretion as a reflection of a drug-
induced alteration in hepatic metabolism. In the biosynthesis of D-glucaric 
acid the last enzymatic step consists in the conversion of D-glucuronoIactone 
into D-glucaric acid, which is mediated by D-glucuronolactone dehydrogenase. 
Aarts and Hinnen-Bouwmans (9) have observed that D-glucuronolactone 
dehydrogenase is identical with aldehyde dehydrogenase from the soluble 
fraction of the liver. Therefore, on the other hand, disulfiram may also inhibit 
the oxidation of D-glucuronolactone and so decrease the D-glucaric acid 
excretion by a direct interference with its formation in the liver. 
Methods 
Animals. 
Male guinea-pigs, weighing 210-250 g, were utilized. All animals were main-
tained on a Standard Laboratory Cavy Diet L.C. 23-B (Hope Farms), with 
free access to water. Disulfiram was administered at a rate of 300 mg/kg/day 
in 2 doses; D-glucuronolactone 4 g/kg/day in 3 doses. Both compounds were 
administered p.o. in 0.9 per cent saline solution. Control groups received 0.9 
per cent saline solution in equivalent quantities. 
Urine samples were collected at 24 hr intervals and stored at —20° С until 
examination. 
Liver preparations. 
For the in vitro experiments the guinea-pigs were killed by decapitation, 
the livers were immediately removed and cooled in ice. Portions of liver were 
weighed and finely minced. Homogenates (20 % ) were prepared in 0.25 M 
sucrose solution, containing 5 Χ ΙΟ"2 M tris (hydroxymethyl)amino-methane-
HC1 (pH 7.4) using a Teflon-glass Potter-Elvehjem type of homogenizer. 
Crude microsomal fractions were prepared from the homogenates by centri-
fugation (9000 g for 20 min). 
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D-glucaric acid assay. 
D-glucaric acid was determined by the chemical method of Ishidate et al. 
(10) with slight modifications. 
An equal volume of 0.1 M sodium borate was added to 1/10 vol. of the 24-hr 
urine sample. The mixture was treated successively with 2,6-dichlorophenol 
indophenol (0.2 ml, 0 . 5 % ; at 20° С for 15 min) and sodium borohydride 
(50 mg; at 20° С for 30 min) to eliminate any possible interference by L-
ascorbic acid and D-glucuronic acid. A few drops of butanol were added during 
sodium borohydride reduction to prevent foaming. Acetone (1 ml) was added 
to decompose any remaining sodium borohydride. After 10 min the urine 
solution was put on a column, and D-glucaric acid was separated by ion-ex­
change chromatography using Dowex 1 χ 8 (200-400 mesh) in borate form. 
Firstly, 0.05 M sodium borate — 0.02 M sodium sulphate (150 ml) was passed 
through the column. Then D-glucaric acid was eluted with 0.05 M sodium 
borate ·— 0.4 M sodium sulphate (35 ml). A 1 ml aliquot of this eluate was 
used for the determination of D-glucaric acid. D-glucaric acid was oxidized 
with periodic acid to form glyoxylic acid. The amount of glyoxylic acid was 
assayed colorimetrically by the method of McFadden and Howes (11). 
Enzyme assays. 
The microsomal N-demethylation of aminopyrine was measured in 9000 g 
supernatants as described by Dewaide and Henderson (12). 
UDPglucuronyltransferase activities were determined in ultra-sonicated liver 
homogenates as reported earlier (13). /¡-Nitrophenol was used as acceptor 
substrate. 
For the study of the inhibition of D-glucuronolactone and aldehyde dehydro-
genase by disulfiram, partially purified enzyme preparations have been used. 
The purification was accomplished as described by Hänninen (14). Liver (12 g) 
was homogenized with 40 ml 0.15 M KCl. After centrifugation of the homo-
genate at 105,000 g for 1 hr, 2/3 vol of saturated ammonium sulphate solution 
(4° C) was added while stirring. The mixture was placed in ice for 10 min 
and the precipitate was removed by centrifugation. A further 1/2 vol of saturated 
ammonium sulphate solution was stirred into the supernatant and after 10 min 
the precipitate was collected by centrifugation. The pellet was dissolved in 
0.1 M sodium phosphate buffer (10 ml; pH 6.5) and applied to a Sephadex 
G-200 column (2.5 cm internal diameter χ 70 cm long). The same buffer 
was used for elution at a rate of 22.5 ml/hr. Fractions of 3 ml were collected 
and tested for dehydrogenase activity. The fraction? with the highest enzyme 
activity were pooled, divided into samples and stored at —20° С until use. 
D-glucuronolactone and aldehyde dehydrogenase activities were measured 
at 37° С by following the rate of N A D + reduction spectro-photometrically at 
340 nm. The incubation mixtures contained 0.55 mM acetaldehyde or 12.5 mM 
D-glucuronolactone, 0.2 ml of enzyme source, and varying concentrations of 
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NAD+, in a final volume of 2.2 ml of 0.2 M glycine buffer (pH 9.2). Disulfiram 
was added with a concentration of 2.5 X 10 - 7 M. 
Protein assay. 
Amounts of protein were determined according to the method of Lowry 
et al. (15). Bovine serum albumin was used as reference. 
Results 
D-glucaric acid excretion. 
The temporal course of the excretion of D-glucaric acid in the urine of 
guinea-pigs, during a 7-days treatment with disulfiram, is illustrated in Fig. 1. 
No influence on the D-glucaric acid excretion could be detected when the urine 
sampling was started directly after the first dosage of disulfiram. A significant 
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FIG. 1 
Effect of disulfiram treatment on the 24-hr urinary excretion of D-glucaric acid in 
guinea-pig. Means are given ( -fc 2 S.E.M ). The average level of the controls ( ± 2 S Ε M., 
for 9 animals) is represented by the broken line. The width of the columns corresponds 
with the period of urine collection. * Indicates significantly different from the control 
at Ρ < 0 001 (Student's <-test). 
decrease in D-glucaric acid excretion was observed when the urine was collected 
during the 16-40 hr period. During further treatment with disulfiram this 
turned into an increase, to reach values up to 200 per cent of the control at 
the 7th day. 
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Effect of dimlfiram treatment on N-demethylase and UDPglucwonyltransferase. 
Enzyme activities for the N-demethylation of aminopyrine and the glucuronyl 
conjugation of p-nitrophenol in the liver have been measured in vitro during 
the treatment with disulfiram for some days. The results are shown in Table I. 
It appeared that treatment for 1 or 2 days did not change any of the enzyme 
activities tested. After 8 days a significant enhancement of the capacity for 
N-demethylation and ^-nitrophenol glucuronidation became manifest. 
TABLE I 
Effect of disulfiram pretreatment on the "in vitro" activities of hepatic N-demethylase and 
UDP-Glucuronyltransj'erase 
Duration of treatment (*) 
(days) 
1 
2 
8 
Control 
N-demethylation (') 
of aminopyrine 
17.1 ± 1.0 (6) 
16.6 ± 1.1 (4) 
« 2 5 . 8 ± 1.2 (9) 
17.1 ± 1.1 (6) 
UDP-glucuronidation (*) 
of /»-nitrophenol 
164 ± 6 (6) 
188 ± 4 (4) 
(«) 219 ± 3 (9) 
174 ± 9 (6) 
ζ
1) Expressed as pinoles formaldehyde produced per hr per g fresh liver. — (') 
Expressed as ¿tmoles ¿»-nitrophenol conjugated per hr per g fresh liver. — (') The animals 
received 1 SO mg disulfiram/kg, twice a day. Controls received the same volume of saline 
only. Mean values are given ± S.E.M. ; the values in parentheses designate the number 
of animals. — (*) Significantly different from the control at Ρ < 0.01 ; for all other values 
Ρ > 0.05 (student's i-test). 
Effect of disulfiram on liver weight and microsomal protein. 
After 8 days of treatment with disulfiram the liver weights per unit of body 
weight were significantly greater than those of the control, as indicated in 
Table II. Also apparent, in Table II, is an increase in the microsomal protein 
content. 
Effect of disulfiram on D-glucuronolactone and aldehyde dehydrogenase. 
In 1951 Graham (16) reported that disulfiram inhibits aldehyde dehydrogenase 
by competing with the cosubstrate NAD+. Recently, Aarts and Hinnen-Bouw-
mans (9) found that D-glucuronolactone dehydrogenase and aldehyde dehy­
drogenase from the soluble fraction of the liver have a number of common 
characteristics, and concluded that both enzymes are identical. It was suggestive, 
therefore, to compare the influence of disulfiram on the in vitro dehydrogenation 
of acetaldehyde and D-glucuronolactone. 
Fig. 2 demonstrates that using a partially purified enzyme preparation from the 
liver addition of disulfiram results in the inhibition of the conversion of acetal­
dehyde and D-glucuronolactone. The inhibition is based upon a competition of 
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TABLE II 
Effect of disulfiram on liver weight and microsomal protein in guinea-pigs 
Pretreatment* 
None (controls) 
Disulfiram 
Liver weight 
(g per 100 g 
body, weight) 
2.80 ± 0.06 (6) 
(') 3.80 ± 0.05 (9) 
Microsomal Protein 
(mg/g liver) 
16.6 ± 0.2 (5) 
(«) 18.5 ± 0.7 (5) 
Total microsomal 
protein in liver 
(mg/100 g body weight) 
46.6 ± 1.1 (5) 
(') 70.5 ± 2.8 (5) 
* Adult male guinea-pigs (210-250 g) received 150 mg disulfiram/kg, in saline twice a day for 8 days. Controls received an equivalent volume 
of saline. Values represent means ± S.E.M. The numbers in parentheses represent number of animals per group. — (') Significantly different 
from control at Ρ < 0.001. — (г) Significantly different from control at Ρ < 0.01 (Student's i-test). 
disulfiram with NAD+. The inhibitor constant of disulfiram appeared to be the 
same in both cases: K t = 1.03 X 10
- 7
 M. D-glucuronolactone is an intermediate 
in the biosynthesis of D-glucaric acid in the liver (6, 17). Administration of a 
relatively high dose of D-glucuronolactone to guinea-pigs results in a high 
concentration of the substrate in the liver, and consequently causes an enhanced 
formation and an attendant excretion of D-glucaric acid in the urine. 
It was investigated whether the in vivo capacity to convert D-glucuronolactone 
into D-glucaric acid can be directly influenced by disulfiram. In order to ensure 
sufficiently high concentrations of disulfiram in the liver the guinea-pigs were 
[μ molea/rng"· hr) 
fl-
6 -
/ 
A 
dieulf iram / 
2.5xlO" 7 M / 
disulf iram 
2.5*10"7M ,-• 
-40 
-20 2 0 UO 
[NAD + ]" 1 ( IO" 3 M J 
F I G . 2 
Double reciprocal plot showing the competitive inhibition of D-glucuronolactone and 
aldehyde dehydrogenase by disulfiram. The assay mixtures contained 0.55 m M acetal-
dehyde (circles) or 12.5 mM D-glucuronolactone (delta's); 0.2 M glycine (pH 9.2); 0.2 ml 
enzyme preparation, and varying concentrations of NAD"1", in a final volume of 2.2 ml. 
Disulfiram concentration was 2.5 Χ Ι Ο - 7 M. 
Note: The K
n
-values of NAD+ are equal for both reactions (K„ = 3.03 Χ ΙΟ"5 M), 
and are equally shifted by the presence of disulfiram (broken lines) (K
m
 — 1.04 X 10~4 M). 
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pretreated with disulfiram for 8 days. Then the animals were loaded with 
exogenous D-glucuronolactone (4 g/kg) in 3 doses: at zero time, at 4 hr and 
8 hr. Collection of urine was started after the first dose. The quantity of D-
glucaric acid excretion in the urine of animals receiving only D-glucuronolactone 
(Table III) was increased about 300 fold as compared with untreated animals 
(see controls in Fig. 1). However, in the presence of disulfiram the excretion 
was only increased about 160 fold. 
TABLE III 
Effect of disulfiram on the urtnary excretion of D-Glucaric acid in guinea-pigs receiving 
D-glucuronolactone 
Treatment 
D-glucuronolactone (') 
D-glucuronolactone ; 
disulfiram (') 
D-glucanc acid excretion 
mg/24 hr 
50.47 ± 7.9 
27 20 ± 1.6 
η 
4 
5 
(') D-glucuronolactone, 4 g/kg, was given orally in 3 doses; at zero time, 4 hr and 
8 hr. Collection of urine was started after the first dose. 
η = Number of animals. 
(*) The animals received 150 mg/kg, twice a day, for 8 days Means with S E M . 
are presented Note. The disulfiram pretreatment results in a lower D-glucanc acid 
excretion (P < 0 001 ; Student's f-test) 
This inhibitory effect of disulfiram on the in vivo formation of D-glucaric 
acid can be also observed without the application of extra D-glucuronolactone. 
In Fig. 1 it is apparent that the urinary excretion of D-glucanc acid is lowered 
when the urine collection was started at 16 hr after the first disulfiram dosage. 
Most likely, at later times during the treatment with disulfiram, the inhibition 
is masked by the stimulative activity of this compound. 
Discussion 
Treatment of the animals with disulfiram for 7 or 8 days caused a significant 
enhancement of the drug-metabolizing capacity of the liver, as represented by 
an acceleration of the oxidative N-demethylation and UDPglucuromdation 
measured in vitro. Associated with this increase in liver enzymatic activities 
is a stimulation of liver growth. Liver weights per unit of body weight increased 
about 35 per cent. The body weights of the guinea-pigs were not influenced 
significantly during the treatment. Disulfiram not only exerted an effect on 
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total liver growth but also led to a slight increase in microsomal protein per 
gram liver. 
On the basis of these results it might be concluded that disulfiram has in­
ductive properties. 
As can be seen in Fig. 1, due to disulfiram treatment, the excretion of D-
glucaric acid in the urine strongly increased. Since it has been found by many 
investigators that the D-glucaric acid synthesis paralelled an induction of drug 
metabolism, due to pretreatment with various compounds, the D-glucaric acid 
test may be considered suitable to diagnose induction. 
The period of response to disulfiram is characterized by a lag period prior 
to the increase of D-glucaric acid. Urinary excretion of D-glucaric acid was 
found to decrease, when the urine was sampled in the beginning of the treatment 
(16-40 hr). This is due to an inhibitory activity of disulfiram on the synthesis 
of D-glucaric acid from D-glucuronolactone as proposed in the introduction. 
After loading the animals with exogenous D-glucuronolactone this phenomenon 
was even more pronounced (Table III). 
With the aid of in vitro experiments using partially purified enzyme prep­
arations it became clear that the interference of the D-glucaric acid synthesis 
by disulfiram is caused by a competition between the drug and N A D + . Equal 
Κ,-vaIues of disulfiram (1.03 X I O - 7 M) were obtained both with D-glucu-
ronolactone and acetaldehyde as substrate. This similarity strongly supports 
the postulate of Aarts and Hinnen-Bouwmans (9) that D-glucuronolactone 
and aldehyde dehydrogenase from the soluble fraction of the liver are identical 
enzymes. 
Much attention has been directed to the inhibitory effect of disulfiram on 
drug metabolism both in vivo and in vitro (3, 4, 18, 19). The results described 
here, showing that disulfiram induces drug metabolism in guinea-pigs, are 
apparently in contrast with previous findings. However, in the present case 
an induction becomes evident only after prolonged pretreatment of the animals. 
The absence of an increase after a few days of treatment may be explained by 
the idea that first an acute inhibitory activity of disulfiram prevails. After con­
tinuation of the treatment this effect is overshadowed by the inductive activity. 
This concept is consistent with the data of Stripp et al. (18) who reported 
that the disulfiram impairment of the in vitro capacity of N-demethylation 
lasted at least 72 hr, but was not detectable after 7 days of treatment. Vesell 
et al. (19), compairing the effect of disulfiram treatment for 4 and 10 days 
on the in vivo drug metabolism in man, also reported that the drug after a 
4 day period caused no further inhibition of drug metabolism. 
Recently Grubner et al. (5) studied disulfiram with regard to its capability 
of inducing drug metabolism in the rat. Inducing properties of disulfiram 
could be demonstrated only on the basis of an enhancement of the ascorbic 
acid excretion in the urine. Aminopyrine N-demethylation by 9000 g liver 
supernatants was not influenced. It should be remarked, however, that the 
rats received disulfiram only for 3 days. 
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In conclusion, disulfiram exhibits a biphasic effect on drug metabolism to 
a certain degree resembling that observed with more commonly studied inhi­
bitors, like SKF-525-A As a rule inhibition becomes evident shortly after 
administration of such compounds; but when given chronically, which in 
practice is the case with disulfiram, the rate of drug biotransformation is 
stimulated. 
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Abstract - Treatment ofguinea-pigs with л-hexane for В days enhanced the m vitro glucuronyl conjugation 
of p-mtrophenol This induction was accompanied by a significantly enhanced microsomal protein con­
tent However, the in vitro rates of the p-hydroxylation of aniline and the N-demethylatlon of aminopyrme 
were slightly decreased and unchanged, respectively, during this treatment An increased urinary excretion 
ol D-glucuronic acid and i>glucaric acid paralleled the induction of UDPglucuronyltransferase The 
excretion of glucuronides in the urine was already enhanced within 24 hr after the first dose of n-hexane 
The conclusion is drawn that n-hexane may cause a direct stimulation of the formation of glucuronides, 
further on long-term treatment, л-hexane may be considered as a specific inducer of the glucuromdation 
system 
Numerous xenobiotics are able to enhance the activity 
of the drug-metabolizing enzyme systems in the liver 
[1] This response of the liver to drug exposure is often 
parallelled by a stimulation of the glucuronic acid 
pathway, which is reflected by an elevated excretion of 
L-ascorbic acid and »glucanc acid into the urine 
Recently, several authors have suggested therefore, 
that the determination of D-glucanc acid and L-ascor-
bic acid in urine may be an indicator of an adaptive 
acceleration of hepatic drug metabolism [1-5] Man, 
other primates and the guinea-pig lack the ability to 
synthesize L-ascorbic acid Therefore an enhanced D-
glucanc acid excretion might be a useful indicator of 
an intake of certain compounds foreign to the 
organism 
The aim of the present study was to establish if n-
hexane, a volatile organic solvent widely employed in 
industry [6], affects drug metabolism and the glucur­
onic acid system in the liver Although a substance of 
low toxicity, л-hexane can cause weakness and sensory 
loss in man on chronic exposure [7] 
The results show that in the guinea-pig the urinary 
D-glucanc acid excretion is enhanced after n-hexane 
treatment The observed alteration has been compared 
with urinary excretion of other metabolites of the glu­
curonic acid pathway and the activities of some hepa­
tic enzymes involved in drug metabolism 
METHODS 
Animals 
Male guinea-pigs, weighing about 190 g, maintained 
on a Standard Laboratory Cavy Diet L С 23-B (Hope 
Farms), with free access to water, were utilized n-Hex-
ane was administered ι ρ in sesame oil at a rate of 3 
or 60 mg/kg/day Control animals received sesame oil 
in equivalent quantities. Urine samples were collected 
daily and stored at — 20° until examination 
Liver preparations 
For the m vitro experiments the guinea-pigs were 
killed by decapitation 24 hr after the last л-hexane in­
jection The livers were immediately removed and 
cooled in ice Portions of liver were weighed and finely 
minced Homogenates (20%, w/v) were prepared in ice-
cold 0-25 M sucrose solution, containing 5 χ ΙΟ - 2 M 
Tris(hydroxymethyl)ammomelhane-HCl (pH 7 4), 
using a Teflon®-glass Potter-Elvehjem type of homo-
gemzer Postmitochondrial fractions were prepared 
from the homogenates by centrtfugation (9000 g for 
20 mm) For preparation of the microsomal fractions 
9000 g supernatants were centriliiged in a Christ 
Omega II Ultracentrifiige at 105,000 g for 1 hr(2°) The 
microsomal pellets from the latter step were gently 
resuspended m the homogemzation medium with the 
Potter-Elvehjem apparatus Suspensions (1 ml) con-
tamed microsomes derived from 02 g of liver 
Urinary assays 
o-Glucaric acid D-Glucaric acid was measured 
according to Marsh [8] from the inhibitory effect of D-
glucarolactone, to which it is converted by heating at 
pH 2 0, on ^-glucuronidase 
Glucuronides Dische's carbazole reaction modified 
by Yuki and Fishman [9] was applied 
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Free D-glucuromc acid. Dische's carbazole method, 
modified by Yuki and Fishman [9] for differential 
analysis was used. The total quantity of Tree and conju­
gated glucuronic acid was determined according to 
Gregory [10]. 
Enzyme assays 
The microsomal JV-demethylation of ammopyrine 
and the p-hydroxylation of aniline were measured in 
9000 g supernatants as described by Henderson and 
Kersten [I I]. 
UDPglucuronyltransCerase (EC 24 117) activity. 
with p-mtrophenol as substrate, was measured in an 
incubation system consisting of 0-04-006 ml microso­
mal suspension. 0-05 ml MgCl2 (3 3 χ ΙΟ"3 M final 
concn). 0-l5ml UDPGA (4 χ I0" 3 M final conen), 
0-1 ml saccharo-l,4-lactone (3 χ IO - 3 M final concn). 
02ml p-nitrophcnol (0-I-0-4 χ 10"'M final concn) m 
Tris HCl buffer (O05 M, pH 7 4). 
The further procedures were done according lo Hen­
derson [12] except that for activation of UDPglucur-
onyltransferase, the microsomal suspensions were 
treated with the detergent Triton X-100 (025"0 final 
concn) instead of somcation The incubation was al 
37 С for 15 mm ('„„-values and K
m
 of p-mlrophenol 
were calculated by extrapolation of Lmeweaver Burk 
plots. 
Protein assay 
Protein was determined according to the method of 
Lowry et al [13], with bovine serum albumin as refer­
ence 
Urinary eKcretion of Ό-glucaric acid, D-glucuromc 
in ul unti qtucuronides Figure 1 shows the urinary D-
glucanc acid excretion with time during treatment 
with n-hexane (60 m&'lcgr'day). As can be seen, the 
D-tІислгіс леісі 
(pg/2th/100g body we\gM) 
150 
rh 
100-i 
50 
7 Vt 21 35 
days of treatment 
Fig 2 Fflectofchronic Irealmenl wilhrelativelylowdosesof 
ii-hexancO mg/kg/day Jon (he 24-hr urinary excretion of iv 
glucanc acid Blocks rcpreseni means (±2 S t M ) for six 
animals The average level of the controls (±2 S Ε M., for 
six animals sampling on days 7. 14. 21 and 15) is repre­
sented by the horizontal line (*) indicates signifìcantly dif-
ferent from the conirol al 0-01 < Ρ <0Ч)2, for all olher 
values Ρ > 0-05 (Student's Mesi) 
amount of D-glucanc acid was enhanced slightly but sig­
nificantly after an initial lag period of about 5 days. The 
same phenomenon was observed for the urinary excre­
tion of free i>glucuronic acid The urinary excretion of 
glucuronides was stimulated by n-hexane treatment 
since a clearly elevated level of these metabolites in the 
urine was observed from the tirsi day of treatment (Fig. 
1) 
As is illustrated in Fig 2, long-term treatment with 
n-hexane for 35 days at a rate of 3 mg/kg/day also in­
duced a statistically significant increase of D-glucanc 
acid excretion 
N-Deinethylation ofaminopyrine and p-hydroxytation 
of aniline At three intervals during n-hexane treatment 
(60 mg/kg/day), aniline p-hydroxylation and amino-
D-jlucfnc »ad . 
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Fig I Effect of n-hexane trea imeni on the 24-hr urinary excretion of o-glucaric acid, free D-glucuromc 
acid and bound as glucuronide in guinea-pig Blocks represent means ( ± 2 S E M \ The numbers of ani-
mals are given in parentheses The average levels of the controls ( ± 2 SEM. for five animals) are repre-
sented by the horizontal line Control sampling occurred on days I 5 and 8 The amounts ofexcreted meta-
bolites are standardized per lOOg body wi (*) indicates significantly different from (he control at 
0-02 < P<0-05,(*')at0-0l < P < 0-02, for all other values Ρ > 0Ю5 (Student's Mest) 
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Table I Effect ohi hexane prelrealmenl on the m vitro ac­
tivities of V-demethylase and ^-hydroxylase 
Duration 
of 
treatment 
(days) 
Activity 
/V-Demethylation* 
оГатіпоруппе 
/î-Hydroxylationt 
of aniline 
1 
Control 
32 1 ± 10 ('S) 
28 7 ± 4 I (5) 
28 2 ±0-6(5) 
29 8 + 10(5) 
3 3 0 ± O-HISHi 
3 31 ±σ04(5)» 
1 44 + 04)1 (5)t 
400 ± &I8(5) 
* Expressed as ßmoics formaldehyde produced/hr/g fresh 
liver 
t Expressed as ßmohs p-aminophenol produced hr/g 
fresh liver 
The animals received 60 mg ri-hexane kg day ι ρ m 
sesame oil Controls received the same volume of sesame oil 
only Mean values are given ± S Ε M the values in paren 
theses designate the number of animals 
Significantly different from the control at 
Î0 -02<P<005 itOOl < Ρ <0·02, « Ρ < 0 0 1 . for all 
other values Ρ > 0-05 (Student's r-test) 
pyrme N-demethylation were measured in tifro From 
Table I it is apparent that the aniline hydroxylatton 
was significantly decreased after I day of treatment 
This decreased value for the enzyme activity did not 
change significantly during further treatment with n-
hexane 
The rate of aminopynne iV-demethylalion remained 
at the control level during the treatment period (Table 
1 ) Also a 35 day treatment period with 3 mg л-hexane/ 
kg/day did not change the in vitro N-demethylase acti­
vity (Table 2) 
UDPgluiuwnyllrainlerase In addition to the mic­
rosomal mixed-function oxidase system, the in vitro 
activity of UDPglucuronyltransfcrase in the liver was 
studied during the treatment with n-hexane Apparent 
K
m
 and V
mix-values were measured with a fixed rela­
tively low p-nitrophenol concentrations ranging from 
0-1 to 0-4mM and a fixed UDPGA concentration of 
4 mM To ensure linearity in the rate of conversion of 
p-nitrophenol with time, preliminary incubations were 
performed to determine suitable quantities of microso­
mal suspension so that not more than 15-35 per cent 
of the p-nitrophcnol would have reacted with UDPGA 
during an incubation time of 15 mm 
It can be concluded from Fig 3, that the apparent 
K„ did not change during n-hexane treatment How­
ever, the apparent
 тж
 for the p-nitrophenol glucur-
onidation was significantly increased after 8 days to 
reach values up to 150 per cent of the control at the 
21st day Treatment (35 days) with 3 mg n-hexane/kg/ 
day also resulted in an increased V
mt, value (Table 2) 
Liter Heiqhl and microsomal protein content As is 
illustrated in Table 3. liver weights, per unit of body 
weight, did not alter significantly during the treatment 
period The microsomal protein content, however, was 
I ρ Nrtroph#nol fflucuronidabon — -, 
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Fig 1 Influence оГп-Нехапе treatment (60mg,kg/da> ιρ) 
on apparent l-^^and K„, of p-nilrophcnol glucuronidation 
by Tnlon X-100 activated microsomal preparations Blocks 
represent medns(±2SE M )of 6 separate experiments
 т
^ 
and K
m
 are expressed as mmoles/hr/g fresh liver and mM 
respectively Control animals were sacrificed on days I. 8 
and 21 {·) indicates significantly different from the control 
at Ρ < σ01, for all other values Ρ > 0-05 (Student's r-lest) 
Table 2 Effect of chronic treatment with low doses of n-hexane on the m vitro activities of hepatic /V-demethylase and 
UDPglucuronyltransfcrase 
Treatment 
None (controls) 
n-Hexane 
N-Demethylalion* 
of aminopynne 
307 ± 2 3 (4) 
310 ± 0-7(4) 
UDPglucuronidalion 
of p-nitrophenol 
Apparent ^ „ t 
013 + 004(4) 
0-4* ± 0-03 (4)t 
Apparent Km (mM) 
089 + O06 
089 ± O10 
Guinea pigs received 3 mg n-hexane/kg ι ρ in sesame oil for 35 days Controls received an equivalent volume of sesame 
oil Values represent means ± S fc M The numbers in parentheses represent number of animals per group 
* Expressed as ¿zmoles formaldehyde produced/hr/g fresh liver 
t Expressed as m-moles />-nitrophenol conjugaled/hr/g fresh liver Enzyme preparations were maximally activated by 
Tnlon X-100 before incubation 
Significantly different from the control at JO-OZ < Ρ < 0-05. for all other values Ρ > 0-05 (Student's ί-testi. 
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Tabic 3 Effect of n-hejanc prctrentmenl on liver weight 
and microsomal protein content in guinea-pigs 
Duration of Microsomal 
treatment Liver wt protein 
(days) (g/100gbody wl) (mg/g liver) 
21 
Controls 
318 ± » 0 8 (5) 
329 ±008(5) 
318 ± 0 0 9 (5) 
3 18 ±019(5) 
29-0 ± 0 9 (5) 
31 6 ± I 1 (5)· 
338 ± 12(5)t 
28-0 ± I 1 (5) 
Guinea pigs received 60 mg л-hexane/kg/day ι ρ in 
sesame oil Controls received an equivalent volume of 
sesame oil 
Values represent means ± S Ε M Values in parentheses 
represent number of dnimals per group 
Significantly differeni from the control at 
•002 < Ρ < 005. tP < 0-01. tor all other values Ρ > 005 
(Student s liest) 
significantly enhanced after 8 days Long-term treat­
ment with л-hexane at low concentration (3mgAg/ 
day) did not measurably change either the liver weights 
per unit of body weight or the microsomal protein con­
tent 
In vitro action ofn-hexane on microsomal enzyme ac­
tivities It might be possible that л-hexane is still pres­
ent in the liver preparations tested for N-demethylat-
mg p-hydroxylating and UDPglucuronidatmg activi­
ties One can expect, however, that the residual 
amount of n-hexane in the liver is very low at 24 hr 
after the last injection, since n-alkanes in general are 
well metabolized [18] 
In order to establish possible in vitro effects of л-hex­
ane this substance was added to preparations from 
livers of untreated animals (Table 4). n-Hexane al a 
final conçu of 0-1 and OS per cdnt (v/v) had no in-
fluence on the activities of yV-demethylating and p-hyd-
roxylating enzymes Studying the in vitro effect of n-
hexane on UDPglucuronyltransferase the compound 
was added to untreated and to Triton X-100 pre-acti-
vated microsomes. n-Hexane strongly activated UDP-
glucuromdation No further activation was observed 
when л-hexane was added to Triton X-100 pre-acti-
vated microsomes. 
DISCUSSION 
Treatment of guinea-pigs with n-hexane does not 
enhance the p-hydroxylation of aniline and the N-
demethylation of aminopynne In fact, a slight de­
crease m p-hydroxylase activity was observed after I 
day of treatment 
No remarkable alteration m activity of these oxida­
tive enzymes was observed on addition of n-hexane up 
to a final concentration of OS per cent to microsomal 
preparations from untreated animals (Table 4) It 
appeared, however, that this in ι uro treatment clearly 
activates p-nitrophenol glucuromdation If ii-hexanc 
was added to Triton X-100 pre activated microsomes. 
no further activation of UDPglucuronyliransferjsc 
occurred 
In contrast, treatment of the guinea-pigs with n-hex­
ane for several days caused a significant enhancement 
of the UDPglucuronyltransferase activity of the Tri­
ton X-100 pre-activated microsomes This enhance­
ment was accompanied by a significant increased mic­
rosomal protein content 
After chronic treatment with low doses of ii-hexane 
(3mg/kg/dayl when the UDPglucuronyltransferase 
was also significantly enhanced, the microsomal pro­
tein content was not measurably altered Because we 
did not find any effect on the apparent K
m
 for the' p-
nitrophenol glucuromdation. it might be excluded that 
alterations in enzyme-substrate affinities are respon­
sible for the observed increase From this and the fact 
that of the drug-metabolizmg enzyme systems tested. 
only UDPglucuronyltransferase shows an increase in 
activity during n-hexane treatment the conclusion 
might be drawn that n-hexane is a specific inducer of 
the glucuromdation system 
In addition, n-hexane also strongly activates m vivo 
the urinary excretion ofglucuronides within 24 hr after 
the first application This might be m accordance with 
the in vitro activation by л-hexane of p-nitrophenol 
glucuromdation (Table 4) However on the basis of the 
present data it cannot be exluded that the enhanced 
excretion of glucuromdes m part is due to increased 
substrate supply to glucuromdation of n-hexane meta­
bolites 
As is seen m Fig 1, the urinary excretion of D-glu-
canc acid significantly increased during n-hexane 
Table 4 Effect of n-hexane addition to 9000 g supernatants from liver homogenates on \-demethylase p-hydroxylase and 
UDPglucuronyltransferase activities 
n-Hexane 
concn 
%(v/v) 
UDPglucuronidaiion of p-nitrophenol* 
N Demcthylation 
оГатшоруппе* 
p-hydroxylation 
of aniline* Untreated 
Pre-treated with 
Triton X-100t 
0 
01 
05 
3144 
3153 
3154 
3 47 
3 81 
3 69 
1107 
19 32 
32 34 
9606 
974)2 
96 54 
* Expressed as /jmoles converled/hr/g fresh liver 
t Enzyme preparations are maximally activated with Triton X-100 (0-25%) before incubation 
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treatment Even a low daily dose of л-hexane (3 mg/kg/ 
day) induces o-glucaric acid excretion after a lag 
perrod of at least 21 days (Fig 2) It has been found by 
several investigators that the D-glucanc acid synthesis 
paralleled an induction of drug metabolism due to 
pretreatment with various compounds From this the 
conclusion was drawn that the D-glucanc acid test may 
be considered suitable to diagnose induction The 
results of this investigation give support to this consi­
deration only as far as induction of glucuronidation 
is concerned 
The mechanism by which drugs stimulate the D-glu­
canc acid biosynthesis is not yet fully understood The 
results of Burns and Evans [IS], Conney et al [16], 
and Evans ft al [17] suggest that the primary effect 
of the stimulating drugs is an increased synthesis of D-
glucuromc acid in the liver cell The increased quantity 
of D-glucuronic acid is subsequently utilized for the 
synthesis of its metabolic endproducts. e g D-glucaric 
acid, L-ascorbic acid Our findings that after n-hexane 
treatment the pattern of the enhanced »glucuronic 
acid excretion equals that of the D-glucanc acid excre­
tion, are in agreement with the above concept How­
ever, further investigations are needed to determine at 
which step m the sequence of enzymic reactions the 
stimulation is initiated 
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Alteration ¡η urinary D-glucaric acid excretion asan indication 
of exposition to xenobiotics 
W.R.F. Notten and P.Th. Henderson 
Institute of Pharmacology. University of Nijmegen, 
Nijmegen, The Netherlands 
Abstract 
Many compounds which are foreign to the organism, particularly those which 
due to their high lipophilicity tend to remain for a long time in the body, are 
capable of stimulating a number of enzymes in the liver. On the one hand this 
affects the enzymes involved in the conversion of lipophilic toxic substances 
into more hydrophilic, non-toxic products. On the other hand the metabolism 
of "normal" body constituents can also be mfluenced. This stimulation, as a 
rule, becomes manifest in an enhanced excretion of metabolites by the urine. 
A well-known example is the stimulation of the D-glucuronic acid pathway in 
the liver, which leads to an enhanced excretion of L-ascorbic acid (in mammals 
excepting primates and the guinea-pig) and D-glucaric acid. 
In view of this, it is questionable whether the measurement of an enhanced 
urinary D-glucaric acid — as a reflection of an altered liver metabolism — can 
serve as a reliable test for the effect of exposure to compounds foreign to the 
body. Such a test might be especially important when exposure takes place 
chronically to known agents at subtoxic concentrations, for which specific test 
methods are absent or hard to perform, and in those cases where exposition 
occurs to a varied spectrum of unknown xenobiotics. 
During the present study a number of xenobiotic compounds (some drugs, 
organic solvents, pesticides and other environmental pollutants) were screened 
for their capacity to enhance urinary D-glucaric acid excretion in the guinea-
pig and rat. The experimental results support the usefulness of the D-glucaric 
acid test as a measure of general exposition. 
As far as the mechanism of stimulation is concerned, it appeared that the 
increased synthesis of D-glucaric acid is directly related to an acceleration of 
the conversion of UDPglucose to UDPglucuronic acid. 
The applicability of the D-glucaric acid test for man in the field of industrial 
and environmental hygiene, is discussed. 
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1. Introduction 
In industrial and environmental hygiene it is of great importance to estimate 
exposition to toxic substances as early as possible and at concentrations which 
do not yet lead to intoxication phenomena. Periodic diagnosing of persons or 
animals for exposure to xenobiotics at subtoxic concentrations may serve a 
double purpose. On the one hand one can guard against unacceptable toxic 
damage by excluding against further exposition, on the other hand indications 
can be found in order to take adequate measures with respect to the sources of 
pollution. 
As a matter of fact, when exposition to certain known agents is the case, as 
often occurs in industry, specific tests are relevant. However, if suitable spe-
cific test methods are either lacking or difficult to perform, and in those cases 
where exposition occurs to a broad spectrum of unknown chemicals, it would 
be of great value to have at our disposal one or more nonspecific test methods. 
1.1. The D-glucaric acid test 
Evidence has accumulated regarding the ability of many compounds, particu-
larly those which due to their high lipophilicity tend to remain for a long time 
in the body, to induce the activities of the various drug-metabolizing enzy-
mes.1"3 Also, it has become apparent that exposure to chemicals foreign to the 
organism often leads to a stimulation of the glucuronic acid pathway in ^hich, 
by sequences of biochemical processes, hexose is transformed via D-glucu-
ronic acid to L-ascorbic acid, D-xylulose and D-glucaric acid (see figure 1). In 
1940 Longenecker et al.6 reported that various drugs administered to rats 
enhanced the urinary L-ascorbic acid excretion. Further investigations have 
extended this phenomenon to other compounds and currently the stimulative 
influence of a large variety of xenobiotic agents is known.^5-8"11 From this the 
suggestion was made that an enhanced urinary excretion of L-ascorbic acid 
may be used as an indicator of drug-induced alterations in the activities of 
drug-metabolizing enzymes in animals. ^ 8 It is of particular importance for 
man, who is unable like other primates and the guinea-pig to synthesize 
L-ascorbic acid, that the stimulative effect of drugs on the glucuronic acid 
pathway also results in an enhanced urinary excretion of D-glucaric acid.11"14 
It was the purpose of the present study to find out if an altered urinary 
D-glucaric acid excretion, in its turn, can be considered as an indication of 
previous intake of certain chemicals. In that case, the D-glucaric acid test 
might be of value as a non-selective exposition test. 
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FIG. 1. 
The D-glucuronic acid pathway. 
2. Methods 
2.1. Animals 
Male Wistar rats (175-230 g) and male guinea-pigs (195-205 g) were utilized. 
All compounds were administered i.p. or p.o. (see tables). Control animals re-
ceived saline or sesame oil in equivalent quantities. 
For the measurements of the in vitro activities of the liver enzymes, the 
animals were killed by decapitation. The livers were rapidly removed and 
cooled in ice. Portions of liver were weighed, finely minced, and transferred 
into 4 vol. of ice-cold 0.25 M sucrose solution containing 5 Χ ΙΟ"2 M tris (hy-
droxymethyl)aminomethane-HCl (pH 7.4). Homogenates were prepared using 
a Teflon-glass homogenizer. Crude microsomal fractions were prepared from 
the homogenates by centrifugation at 9,000 g for 20 min at 2°C 
2.2. Determination ofD-glucaric acid in the urine 
D-glucaric acid was estimated according to the method of Marsh1 9 from the 
inhibitory effect of D-glucaro-l,4-lactone, to which it is converted by heating 
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at pH 2, on /î-glucuronidase. 
Creatinine concentrations in the urine were estimated according to the 
method of Gorther and de Graaff.20 
2.3. Enzyme assays 
Microsomal N-demethylation of aminopyrine was measured in 9,000 g super-
natants as described by Henderson and Kersten.21 
UDPglucuronyltransferase activities were determined in 9,000 g super-
natants according to Henderson,22 except that for activation of the enzyme the 
supernatants were treated with the detergent Triton X-100 (0.25%, final cone.) 
instead of sonication. p-Nitrophenol was used as acceptor substrate. 
2.4. Protein assay 
Protein concentrations were determined according to the method of Lowry et 
al.23 Bovine serum albumin (Sigma) was employed as reference standard. 
3. Results and discussion 
3.1. Comparison of the effects of chronic treatment with xenobiotics on drug 
metabolism and on urinary excretion ofD-glucarate 
It has been postulated by Hunter,12·15 Latham24 and others that the urinary 
D-glucaric acid excretion might act as an indirect estimate of hepatic enzyme 
activity. In the present study, we have examined whether alterations in enzyme 
activities involved in drug metabolism appear after treatment with various 
compounds, and whether such alterations are paralleled by similar changes in 
urinary D-glucarate levels. 
Guinea-pigs were treated with relatively low doses of different xenobiotics, 
including some drugs, pesticides and hydrocarbons for several weeks. The 
effect on the in vitro activities of the oxidative N-demethylation of amino-
pyrine and the UDPglucuronidation of p-nitrophenol (two typical examples of 
drug-metabolizing reactions) is demonstrated in table I. Only disulfiram, 
ethanol and aniline treatment led to an enhanced rate of N-demethylation and 
glucuronidation. Perthane, tetraethyllead, Dodin and dimethoate increased 
only the N-demethylating activity, whereas hexachlorobenzene, Aroclor 1260, 
я-hexane, nitrobenzene, and benzene enhanced only the activity of UDPglucu­
ronyltransferase. In contrast, the glucuronidating activity was found to be 
reduced after treatment with phenylmercuric acetate. Heptachlor, toluene and 
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TABLE I 
Effect of chronic treatment with xenobiotics on in vitro activities of hepatic N-
demethylase and UDP-Glucuronyltransferase 
Compound 
hexachlorobenzene 
heptachlor 
disulfiram 
Perthane 
toluene 
tetraethyllead 
Aroclor 1260 
ethanol 
я-hexane 
Dodin 
Atrazine 
dimethoate 
nitrobenzene 
aniline 
benzene 
phenylmercuric acetate 
dose* 
10 
4 
300 
100 
60 
1.5 
1 
100 
3 
14 
10 
7 
0.5 
1 
1 
1.5 
N-demethylation1 
of aminopyrine 
control 
77 ± 1 
77 ± 9 
95 ± 6 
90 ± 5 
85 ± 8 
90 ± 5 
1 0 8 + 9 
90 ± 5 
108 ± 9 
77 ± 9 
83 ± 4 
77 ± 9 
108 ± 9 
85 ± 8 
108 ± 9 
90 ± 5 
treated 
77 ± 1 
81 ± 2 
J43 + 7XXXX 
1 2 3 ± 2 X X X ) < 
108 ± 8 
1 0 5 + 3 X 
94 ± 5 
111 ± 7 X 
91 ± 4 
37 ± 7 X X X 
86 ± 4 
55 ± I х 
107 ± 5 
1 1 4 ± 4 X 
123 ± 7 
95 ± 8 
UDP-glucuronidatione 
of p-nitrophenol 
control 
52 + 3 
52 ± 3 
58 ± 3 
45 ± 2 
46 + 4 
45 + 2 
49 ± 6 
45 + 2 
49 ± 6 
52 ± 3 
46 ± 5 
52 ± 3 
49 ± 6 
46 ± 4 
49 ± 6 
45 ± 2 
treated 
64 ± 2 X X X 
46 ± 1 
73 ± 1 X X X X 
46 ± 1 
44 ± 4 
46 ± 1 
6 7 ± 3 X 
54 ± г™ 
70 + 4 х 
4 4 ± 4 
41 + 5 
47 ± 2 
77 ± 5 X X 
6 0 ± 5 X 
6 9 ± 5 X 
26 ± 4 X X X 
* in mg/kg/day ;all compounds were administered i.p. in sesame oil, except for disulfiram, 
which was suspended in saline and given p.o. The duration of treatment is given in table II. 
' Expressed as 10~* moles formaldehyde produced per hour per mg of microsomal protein. 
ф
 Expressed as 10~7 moles p-nitrophenol conjugated per hour per mg of microsomal protein. 
Values are means (i S.E.M.) of six animals. 
X X X X
: indicates significantly different from control at Ρ < 0.001; x x x : idem at 0.001 < Ρ 
< 0.01; x x : 0.01 < Ρ < 0.02; x : 0 02 < Ρ < 0.05; for aU further values Ρ > 0.05 (Student's 
t-lest). 
Atrazine exhibited no influence on the in vitro activities of these drug-meta­
bolizing enzymes. From these results it can be concluded that several of these 
compounds can act as specific inducers with regard to drug metabolism. 
As is seen in table II, treatment of the guinea-pigs with most of the chemi­
cals under investigation led to a significantly enhanced excretion of D-glucaric 
acid. Only dimethoate, nitrobenzene, aniline, and benzene did not exhibit a 
measurable influence, whereas phenylmercuric acetate markedly lowered the 
urinary D-glucaric acid excretion. 
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TABLE II 
Effect of chronic treatment with xenobiotics on the urinary excretion of D-glucanc 
acid in the guinea-pig 
Compound* 
hex achloro benzene 
heptachlor 
disulfiram 
Perthane 
toluene 
tetraethyllead 
Aroclor 
ethanol 
л-hexane 
Dodrn 
Atrazine 
dimethoate 
nitrobenzene 
aniline 
benzene 
phenylmercunc acetate 
10 
4 
300 
100 
60 
1 5 
1 
100 
3 
14 
10 
7 
0.5 
1 
1 
1.5 
D-glucanc acid® 
(imcrogram/24h) 
control 
80 ± 6 
80 ± 6 
86 ± 3 
76 ± 7 
72 ± 7 
76 + 7 
74 ± 5 
76 ± 7 
74 ± 5 
80 + 6 
79 + 6 
80 ± 6 
74 ± 5 
74 ± 5 
74 ± 5 
76 ± 7 
treated 
3 7 2 + 5 5 x * x 
301 ± 2 5 x * x 
166 +&*** 
122± 1 2 x x 
96 + 4 x 
103 ± 7 X 
9 8 ± 6 X 
101 ±6* 
9 5 ± 4 X 
103 1 7 х 
9 4 ± 2 X 
94 ± 11 
86 ± 8 
82 ± 8 
78 ± 9 
46 ± 10 х 
per cent 
of 
control 
465 
376 
193 
157 
133 
132 
132 
129 
128 
128 
119 
118 
116 
111 
105 
51 
penod 
(days) 
A 
21 
21 
8 
21 
21 
21 
35 
21 
35 
21 
21 
21 
35 
35 
35 
21 
В 
7 
7 
3 
14 
21 
21 
35 
14 
35 
21 
21 
— 
— 
-
— 
14 
+
 in mg/kg/day, all compounds were administered i.p. in sesame oil, except for disulfiram, 
which was suspended in salme and given p.o. 
β Expressed as microgram/24 h/100 gram body weight, values are means (± S Ε M.) of six 
animals. 
B. indicates the day at which the first significant (P < 0 05) alteration in the urinary ex­
cretion of D-glucanc acid was observed. 
A. indicates the total duration of the treatment. The D-glucanc acid levels mentioned 
were measured during the last 24 h of this penod. 
) < x x
. means significantly different from control at Ρ < 0.001, ^ idem, at 0 01 < Ρ < 0.02, 
x
 0.02 < Ρ < 0.05. For all further values Ρ > 0.05 (Student's t-test). 
Obviously, induction of the drug-metabolizing system is not always accom­
panied by an enhancement of the urinary D-glucarate excretion, as is de­
monstrated by the action of dimethoate, nitrobenzene, aniline and benzene. 
On the other hand, heptachlor, toluene and Atrazine stimulated the glucu­
ronic acid pathway, but left the drug-metabolizing enzymes unaffected. 
44 
3.2. Effect of short-term treatment on the D-glucaric acid excretion 
The conclusion that stimulation of the D-glucuronate pathway, leading to an 
enhanced D-glucaric acid excretion, is not necessarily related to an induction 
of the drug-metabolizing enzymes is further supported by the results from 
some short-term experiments. Rats were treated for 8 hours with relatively 
high doses of barbital, phénobarbital, nikethamide, chlorbutol and DDT. 
Guinea-pigs were treated with Perthane for 24 hours, as indicated in table III. 
No alteration in N-demethylase and UDPglucuronyltransferase activities 
could be observed at the end of the treatment period. However, it is apparent 
from the data given in table III that all the compounds caused a significant 
enhancement of the D-glucaric acid excretion within 8, or 24 hours, respect-
ively. 
Further experiments indicated that stimulation of the D-glucuronate path-
way presumably is based on an accelerated synthesis of UDPGA. Also, it 
appeared that, at least in cases of short-term treatment, this stimulation is 
independent of a drug-induced de novo synthesis of UDPGdehydrogenase, the 
enzyme which catalyzes the conversion of UDPG into UDPGA." 
TABLE III 
Effect o f short-term treatment with relatively high doses of some xenobiotic agents 
on the urinary excretion of D-glucaric acid 
Compound* 
barbital sodium 
phénobarbital 
nikethamide 
chlorbutol 
DDT 
Perthane 
D-glucaric acid** 
control treated 
104 ± 8 330 і З б * * * 
104 ± 8 224±24'< , (x 
104 ± 8 272 ± 3 6 * * 
95 ± 8 1 3 5 + 1 4 х 
95 ± 8 188±20Χ χ χ 
151 ± 1 4 4 2 3 ± 4 9 > < x x 
per cent 
of 
control 
317 
215 
261 
142 
198 
324 
treatment 
period 
(h) 
8 
8 
8 
8 
8 
24 
* barbital sodium (150 mg/kg, i.p.), phénobarbital (130 mg/kg, i.p.), nikethamide (130 
mg/kg, i.p.), chlorbutol (150 mg/kg, p.o.), and DDT (60 mg/kg, p.o.) dissolved in saline were 
administered to male Wistar rats (175-230 g) in two doses, at zero time and at 4 h. Controls 
received an equivalent volume of saline. Perthane dissolved щ sesame oil was administered i.p. 
(500 mg/kg) to male guinea-pigs (195-205 g); control animals received an equivalent volume 
of sesame oil. 
** Amount of D-glucaric acid present in the urine collected during the whole period. 
Values represent means (i S.E.M.) of six animals. 
'
0 < x
: significantly different from the control at Ρ < 0.001; **: at 0.001 < Ρ < 0.01; x : at 
0.02 < Ρ < 0.05 (Student's t-test). 
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3.3. Normal values of the urinary D-glucaric acid excretion in man 
On account of the results obtained from the animal experiments as mentioned 
above, the D-glucaric acid excretion can be used as an index of hepatic enzyme 
induction only in particular cases. Irrespective of an enzyme induction, it was 
evident that, in the majority of cases, treatment with xenobiotics caused a 
clear alteration in the D-glucaric acid level. Therefore, the usefulness of the 
D-glucaric acid excretion as a non-selective exposition test must be seriously 
considered. This prompted us to extend our studies to the D-glucaric acid 
excretion in the urine of man. 
Normal values were determined according to the procedure described by 
Riimke and Bezemer.18 In this method for statistical analysis of normal values 
two types of tolerance limits are distinguished. The inner limits for percentiles 
are recommended as warning limits, the outer limits as limits for more des­
criptive purposes. 
With respect to the general applicability of the D-glucaric acid test, collect­
ing urine for 24 hours may encounter some practical difficulties. Therefore, 
normal values of D-glucaric acid which are related to the urinary creatinine 
concentration, have been compared with the D-glucaric acid excretion per 
hour, both for 24 hours urine collections and urine samples collected over­
night. 110 Young healthy human subjects were tested in this study. The results 
TABLE IV 
Normal values of urinary D-glucaric acid excretion in man 
Urine ^ D-glucaric acid/mg creatinine 
mean inner limits for ou ter limits for 
coUected for 24 h (A) 
collected overnight (B) 
A minus В 
9.9 
9.8 
10.3 
P 2.5-P97.5 
5.4- 15.5 
5.2- 15.3 
4.3- 17.6 
P2.5-
3.7-
3.4-
2.5-
•
p97.5 
• 17.2 
• 16.0 
•20.7 
Uring MB D-glucaric acid/hour 
mean inner limits for outer limits for 
collected for 24 h (A') 
collected overnight (B') 
A' minus B' 
The confidence intervals for the percentiles ?2 5 and P ^ 5 are constituted with γ = 90%. 
The number of samples was 110. 
635 
603 
663 
P2.5 - p 97.5 
349-999 
260- 1150 
307- 1083 
p 2.5 - p 97.5 
219- 1373 
177- 1253 
191- 1437 
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are presented in table IV. No substantial fluctuations in the daily D-glucaric 
acid level occur. Further, it can be derived that reliable values of the D-gluca-
ric acid excretion can be obtained if expressed per mg creatinine. 
Further investigations are in progress now in which persons working in dif-
ferent branches of the chemical industry are being tested for urinary excretion 
of D-glucaric acid (see figure 2). In this manner we hope to assess the validity 
of the test in industrial and environmental hygiene. 
pg Dgkjcarate/mg creatinine 
4 0 i -
FIG.2. 
Urinary excretion of D-glucaric acid in workers with exposure to endrin and office 
workers (control group) of the same factory. The horizontal, broken line indicates the 
outer tolerance limit for P97.5. 
Note: Nearly all persons of the endrin group exhibit a significant enhanced D-gluca-
ric acid excretion. 
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Action of n-alkanes on drug-metabolizing enzymes 
from guinea-pig liver 
W I I I K I I D R 1- N O T T I ч and Pi и R T M H I NIM RSOS 
histiluk of Pharnucologv ^jLulty oí Mi-diuiu. L mvi.rsit> of Nijmtgtn Nijmegen Tht Nclhcrlands 
(Ridi l l i / IK ОипЫі 1474 м и pli ,1 10 O m »ι/» ι ІЧ74І 
Alntricl Trcdlmonl of guinea pig liver mitrosomal preparations «itli ιι pentanc ir hexane and 
и heptane enhantid bolh ρ nitrophinol and n aminuphtnol glucuromdalion Itic apparent К
я
 values 
of I DPglucuronate for both ρ nitrophenot and n aminophcnol UDPglucuronyltransfcrasc and of 
π aminophenol were eonsiderahlv increased whereas the apparent Km \alue of /> nitrophenol was Ihc 
same after и pentanc treatment No solubilization of UDPglucuronyllransfcrase or other microsomal 
proteins was observed after treatment with the n alkanes However a substantial release of phospholipids 
from mierosomal membranes occurred The relative car>acit> of the difTcrcnl alkanes to release phospho­
lipid was the same as the relative activation of UDPglucuronyltranslerase Aniline p-hydroxylation 
was considerably increased by Ihc alkanes at concentrations of about І ^ 4) limes lower than those 
necessary for optimal activation of I DPglucuronyltransferasc At these concentrations no activation 
of the ammopvrmc N demethvlation was observed whereas at higher concentrations a gradual decrease 
in both 4 dcmethylating and ρ hydroxylating activities occurred и Heptane at a concentration which 
optimally activated aniline ρ hydroxylation markedly increased the rate of NADPH<ytochrome P-450 
reduction This suggests that the increase of the ρ hydroxylatmg rate by и heptane is related to 
a reversal of the cytochrome Ρ 45<) reduction by aniline 
Most of the enzymes which are involved in the meta­
bolism of compounds foreign to the organism are 
located in the endoplasmic reticulum of the liver cells. 
firmly bound with this network of membranes 
Studies with membrane perturbing agents have indi­
cated that the activity of these enzymes is dependent 
upon phospholipids and membrane structure Deter­
gents [ I 4] phosphohpases [4 5] ageing [6 7] and 
sonication [ 8 ] enhance the m turo activity of U D P ­
glucuronyltranslerase (EC 2 4 1 17) The mechanism 
of activation has not been fully elucidated It has 
been suggested that the glucuronidating enzymes are 
covered by other membrane components [9 22] 
Treatment of liver microsomal preparations with sur­
factants may alter the membrane structure resulting 
in an enhanced membrane permeability [2] On the 
other hand it has been postulated that on treatment 
UDPglucuronyltransfcrase exhibits diflerent confor­
mational stales with different kinetic properties [ 5 ] 
The activities of oxidative drug metabolizing 
en/vmes of the liver, arc inhibited by surfac­
tants [2 21] chaotropic agents [ 9 ] and phosphoh-
pase С [16] whereas acetone [16 26] and magne­
sium [27] exhibit stimulatory effects 
In our previous work [12] we observed that addi 
tion of n-hexane to liver microsomal preparations con­
siderably increased UDPglucuronyltransfcrase acti­
vity No alterations in the p-hydroxylalion and .V-
demcthylation cn/yme activities were found with the 
ii-hexanc concentrations used In order to understand 
this, the in ι imi effects of n pentanc и hexane and 
u-heptane on drug metaboli/mg cn/vmes are de 
scribed in this report 
MtTHODS 
Vínroviiiiüí pr¡parutions Adult male guinea-pigs 
02S ISOglwere maintained on a Standard Cavy Diet 
L C 21-B (Hope Farms) The animals were killed 
by decapitation The livers were immediately removed 
and cooled in ice Portions of liver were weighed 
and finely minced Homogenatcs (20o„, w/v) were pre-
pared in either ice-cold (V25 M sucrose solution, con-
taining 50 mM Tris HCl buffer (pH 7 4), or in ice-
cold 0-15 M KCl using a Teflon glass Potter-Elveh-
jem type of homogemzer The homogenate was centri-
fuged at 9 0001/ for 20mm Microsomes were 
obtained by centnfuging the 9 000i/ supernatants at 
I05,000(/ for I hr The microsomal pellets from the 
latter step were gently rcsuspended in the homogeni-
zation medium One ml of suspension contained 
microsomes derived from 0 2 g of liver 
The microsomal preparations were treated with 
various amounts of n-pcntane ii-hexane or л-heplane 
Microsomal suspensions (10ml) were shaken on ice 
for 20 mm prior to the enzyme assays, with volumes 
of the n-alkanes ranging from 5-700μ1 It was 
observed that the supernatant hydrocarbon layer fully 
disappeared after shaking for 20 mm 
It is known that alkanes do not mix with water, 
however, they can absorb or dissolve in protein solu­
tions [28 10] Therelore asa measure of the amount 
of n-alkane absorbed or bound by the microsomal 
particles, the term concentration" CV ν ν) is used in 
this paper indicating the amount of alkane present 
in the microsomal suspension 
Enrvmi- ussuis Microsomal Vdemcthylation of 
aminopynnc and ρ hydroxylation of aniline in the 
microsomal suspensions were measured according to 
the method of Henderson and Kersten [ Π ] 
UDPglucuronyltransfcrase activity was measured 
with the acceptor substrate p-mtrophenol or o-amino-
phcnol The p-nitrophenol incubation system con­
sisted of 0 10 ml microsomal suspension. 
(M)S ml M g C l , ( 1 1 m M final concn), 0 15 ml UDPglu-
curonatc (4 m M final concn). 0 1 ml saccharo-l 4-
lactone (1 m M final concn) 0 2 ml p-mtrophenol 
(0 4 m M final concn) in Tris HCl buffer (50 m M pH 
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UDP GLUCURONYLTRANSFERASE 
«â 2« 
i! 
L. υ 
\ 
\ _ 
Per cent hydrocorbcn (v/v) tn microsomot suspension 
Fig I Effect of ii-alkancs on the glucuronidation οΓ ρ nilrophenol and c-drmnophenol in guinea-pig 
liver microsomes. Each pomi indicates the mean of Ì- 6 experiments. 
74). The further procedure, except sonication. was 
accomplished according to the method of Hender-
son [14] The o-ammophenol incubation system con-
sisted of №20 ml microsomal suspension. 
005 ml M g C h (13 m M final concnX 0-15 ml UDP-
glucuronate (4 m M final concn 10-3 ml o-aminophenol 
(03 m M final concn, in 02 o ,, ascorbic acid). 0 1 ml 
saccharo-l.4-lactone (3 m M final concn ) in glycylgly-
cine bufier (50 m M pH 7 7) o-Aminophenyl gluiur-
onidcs were assayed according to the method de­
scribed by Mills and Smith [ I S ] 
NADPH-cytochrome P-450 reductase activity was 
assayed as described by Gigon и al [23] and subse­
quently modified by Vainio and Hanmnen [16] The 
assay mixture (3-0 ml) contained 2 3 mg imcrosomal 
protein, 2 mM glucose, and 10 tu glucose oxidase 
(Boehrmger, GFR) in K H 2 P 0 4 N a : H P 0 4 buffer 
(01 M final concn, pH 7 S) The reaction was started 
by addition of N A D P H to a final concn of 0-4mM 
The formation of reduced СО-cytochrome P-450 
complex was measured at 450 nm with a Cary I IM. 
spectrophotometer at 20° The change in absorbance 
was recorded for approximately 2 mm Due to the 
spectrophotometer used, the first rapid phase of 
reduction could not be measured 
Anal)¡ical methods Protein was determined by the 
method of Lowry et al [18], with bovine serum albu-
min as standard 
Phospholipids were estimated by their content of 
total phosphorus, assuming that I g of phosphorus 
is derived from 25 g phospholipid After treatment 
of the microsomal suspensions with the n-alkancs. 
the microsomes were recentrifuged at lOSOOOi/ for 
I hr Total lipid phosphorus was extracted from the 
supernatant and determined by the method of С hen 
f i al [19]. modified by Ames and Dubin [20] 
>4ггіііагм>л of VDPgUiíuronsltransferav Treatment 
of the microsomal preparations with ii-pentane />-
hexane, and n-heptane resulted in a substantial acti-
vation of both fi-nitrophenol and o-ammophcnol glu-
curonidation (Fig I) The concentration at which the 
л-alkanes display their maximum effect increases with 
a decrease in the carbon chain length On the other 
hand it is apparent that the extent of activation de­
creases with the chain length of (he ii-alkanes. viz 
the longer the carbon chain the smaller the eflect 
Treatment with n-pentane. n-hexane. and n-heptane, 
respectively, led to an approximately 9-, 5- and V o i d 
increase in the rate of p-nitrophenol glucuronidatioa 
and to a 4-, 3- and 2-fold increase in o-ammophenol 
glucuronidation (Table I) It is also evident in this 
table that the extent of the activation by n-pentane 
is comparable with the maximum activation due to 
Triton X-100 No further increase in the activity of 
/i-mtrophenol UDPglucuronyllransferasc occurred 
after successive treatment of microsomes with Triton 
X-100 and n-alkancs In fact a decrease in o-amino 
phenol glucuronidation was observed 
A comparison of the apparent Km values of the 
respective susbslrates and UDPglucuronate for the 
glucuromdatmg enzymes in untreated and n-pentane 
treated microsomes is given in Table 2 The apparent 
Km of p-mtrophenol was not appreciably changed 
by n-pentaie in contrast to the Km value of σ-aimno-
phenol The K „ values of UDPglucuronate consider­
ably increased both for /i-mlrophenol UDPglucur-
onyltransferase and c-aminophenol UDPglucuronyl-
translèrase 
Relea·* о] ткгочотаі lonipaiwnis In order to 
determine whether the activation is due to solubiliza­
tion of the glucuronidating enzymes, the microsomal 
suspension was recentrifuged at 105.000 g The 
1050000 pellet and supernatant were tested for glu-
curomdaling activity and protein content The results 
arc presented in Table 3 It can be seen that, at 
concentrations which lead to maximum activation. 
Tahlc I Effect of some и alkanes on L/DPgtucuronylfrans-
fcrusc in IUII>C and in Triton X 100 aitivated microsomcs 
from guinea-pig liver 
Trcaimenit 
ρ Nilrophenol 
glucuronidation* 
о Aminophenol 
glucuronidation* 
Τπιοη X ИГО 
С ontrol 
η Pcnlanc 
ir Hexane 
и Heptane 
+ 
2 14 
241 
2 10 
2 29 
-
0-27 
:'¡6 
146 
ОНО 
+ 
0171 
0-0H5 
0-056 
0044 
-
0018 
0 165 
0-091 
0-059 
* Expressed as /imolcs substrate conjugated per hr per 
mg microsomal prolem 
t Triion X KM) η регшпе »-hexane and м-heptane were 
added to ι he microsomal suspensions in conens of 025 
* 5 1 5 and 1 ÍY „ (v v) respectively 
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T d b k 2 Effect of fi-penunc on the apparent Km values 
of ρ mtrophenol. »-aminophcnol and I'OPgtucuronatc for 
(JDPglucuronyllran^rcrase in guinea-pig liver mtcrosomes 
Table 4 Release of phospholipid from guinea-pig liver 
microsomal preparations after treatment with n-alkancs 
Apparent Km ( m M ) 
Substrate Treated with 
ii pentarx. 
O S wi 
ρ Nitrophenol 
UDPglucuronalc 
o-Amtnophenol 
I DPglucuronate 
0 12 
O M 
(H)l 
«•10 
0 0 4 
Km values of ρ nitrophenol and tJ-aminophenol were 
determined with concentrations ranging from 0 02 to 
0-2 m M and from 0 0 6 ю 0 Ю m M respectively and a 
fixed UDPghicuronale concentration of l O m M 
The Km of I'DPglucuronate for p-mtrophenol L D P g l u -
curon>ltransferase was measured with UDP-glucuronatc 
concentrations ranging from 0 1 to l O m M and a fixed 
p-nitrophenol ю men ι rat ion of O l m M 
The Km of U DPglucuronate for i w m m o p h e n o l glucur-
onidation was determined with Loncentralions ranging 
from 0 0 1 to OIO m M and a constant concentration of 
o-aminophenol of Ο Ί m M 
the H-dlkdiKs d i d not solubilise I D P g l u c u r o n y l t r a n s -
ferase or other microsomal proteins It appeared 
however that treatment of the microsomes w i t h the 
n-alkanes at these concentrations caused a substantial 
release o f phospholipids f r o m the membranes T h e 
relative capacity of ihe different alkanes to release 
phospholipid ( T a b l e 4 ) is the same as the relative 
act ivat ion o f U D P g l u c u r o n y l t r a n s f e r a s e ( T a b l e I ) 
Efft'il on the UMJÜIUV enzvm \}\U'm T h e ι ι-
alkanes. at low concentrations, h a d no influence o n 
the in n f r o rate of a m m o p y n n e Л - d e m e t h y l a t i o n 
H o w e v e r after treatment o f the microsomes w i t h n-
alkanes at concentrations above 0 5 per cent (v-v) 
a gradual decrease in Λ -dcmethylating activity was 
observed ( F i g 2) 
Treatment* 
mg phospholipid 
mg protein 
Per cent 
relea set 
Ι η ι rea ted 
«- Pen tane 
κ Η ciane 
ii-Hcptane 
0 7 2 
0 5 0 
0 5S 
0 6 2 
\4 
3 1 5 
24 6 
151 
* IO ml microsomal preparations were shaken on ice 
» i l h » И ml /ι penta ne 0 1 5 m! /r-hexanc, and O l ml 
I I heptane respectively for 20 mm 
t Native control microsomes contained 7 1 mg phospho­
lipid per mg protein 
After treatment w i t h n-pentane, n-hexane or л-hep-
tanc the ш atro / i-hydroxylation of anil ine increased 
lo 140, 170 a n d 2 7 0 per cent, respectively ( F i g Эк 
It should be noted that this st imulation occurred 
at hydrocarbon concentrations of a b o u t 1 5 - 3 0 times 
lower than those necessary for o p t i m a l act ivat ion of 
AMINOPYRINE /V-DEMtTHYLASE 
ο ο. ι 
Е е 
5 0 
о о 
02 04 0 6 0 8 10 
Per cent hydrocarbon ( v / v ) r microsomal 
suspension 
Fig 2 Efleci of n j l k j n e s on Ihe V-dcnKihylation of 
dminopynnc in guinea pig liver microsomes Each point 
indntttcs the mean of 1 6 experiments 
Distribution of UDPglucuronyltransfcrasc activity and protein between the 105OOOtf pellet and supernatant 
after treatment of guinea-pig liver microsomes with η alkanes 
Control 
ii-Pentanc 
/і-Нечапе 
«/-Heptane 
UDPgluLuronyllransferase activityt 
In pellet In supernatant 
^-Nitrophenol о Aminophenol ρ Nitrophenol o-Ammophcnol 
7 15 
71 20 
421(1 
: i 2 l 
I 2b 
640 
1 14 
2 29 
0 2 1 
0 2 2 
0 2 5 
0 24 
0 0 2 
ООН 
O02 
0-01 
In pellet 
Protein concentration^ 
I n supernatant 
( ontrol 
n Pentane 
и Hexane 
M Heptane 
2KA 
27 К 
2 9 4 
294) 
2 16 
2 24 
2 26 
2 10 
• Microsomal suspensions were treated with и pentane ( t 5"„l. и hexane ( I *".X and n-hepune ( l - 0 * o t for 2 0 m m . 
and then re-ccnlrifuged at 105(ХЮі/ for I hr 
t bxpressed as /imoles conjugated per hr per g fresh liver 
X In mg per g fresh liver 
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ANILINE ρ-HYDROXYLASE 
Per cent hydrocarbon (v/v) in microsomal suspension 
Fig 3 Effect оГл-alkancs on the /bh>drox)lalion of aniline 
in guinea-pig liver microsomes Each point indicates the 
mean of 1 6 experiments 
UDPgl ucuronyltransferase Contrary to UDPglucur-
on> I transferase activation, η-heptane was the most 
active stimulant of p-hydroxylase activity 
Effect on the rate of cytochrome P-450 reduction 
In order to understand the mechanism of the acceler­
ating action on the aniline hydroxylalion, the in­
fluence of π-heptane on the rate of NADPH-linked 
cytochrome P-450 reduction was studied As can be 
seen in Table 5, π-he ρ ta ne at a concentration of 0-07 
per cent, which is optimal for activating aniline hy-
droxylation, was found to increase markedly the rate 
of NADPH-cytochrome P-450 reduction both in the 
absence and in the presence of aniline Aniline inhi­
bited significantly the rate of cytochrome P-450 
reduction Addition of »-heptane to the hepatic mic­
rosomes in a concentration of 10 per cent, which 
did not exert an e fleet on thep-hydroxylatmg activity 
had no significant influence on cytochrome P-450 
reduction 
DISCI SSION 
The results demonstrate that n-pentane, л-hexane. 
and n-heptane are able to activate p-nitrophenol and 
ibaminophenol UDPglucuronyltransferase to a 
degree comparable with the action of Triton X-100 
Recently a slight activating efTeci of n-hexanc on the 
in vttro glucuronidation of ρ η Itrop he no I in rat liver 
Table 5 Fffiecl of »-heptane on the NADPH-cytochrome 
P-450 reductase activity in hepatic microsomes from the 
guinea-pig 
Bali, of i.)UKhronK Ρ 4M) a d u i u o n " 
Amimi. 
Addinoli < : < m M > So jnr l i rx 
S o m k u n t r o l ) Il l i f t + I H i » ( < | IHWf> ·»• IMII4|1| 
» mpuih. IIHI ι о іч<і + iMHtst(41 ι*;** * і)шк;гм 
» HepUFK. |И1"о) ІНЧ) + ΙΜΪΙ1|4| II IM - IMK)S|-I) 
* Mean values, expressed as nmoles converted per mg 
microsomal protein per mm are given ± 2 S t the 
number of experiments is given in parentheses 
'("Significantly different from com rol with aniline al 
O00I < Ρ < 0-01 (Students ( test» 
X Significantly different from (.ontrol without aniline at 
0 0 0 1 < Ρ < 0-01 (Students f-icst) 
mKrosomes has been reported by Vaimo [22] How­
ever. the concentrations of n-hexanc used were much 
higher than those found to be optimal for activation 
of guinea-pig UDPglucuronyltransferase in the pres­
ent study 
И is generally accepted that the activity of L) DPglu-
curonyltransferase is strongly dependent upon the 
structure of the microsomal membrane Disruption 
of the microsomal vesicles with several surfactants 
caused an activation of UDPglucuronyltransferase 
concomitant with a release of proteins from the mic­
rosomes [2] On treatment of guinea-pi g liver micro­
somes with fi-alkanes, solubilization of glucuronidat-
mg enzymes or releases of other proteins was not 
observed whereas a liberaіюп of phospholipids from 
the microsomal membranes occurred 
The dependency of UDPglucuronyltransferase acti­
vity on membrane phospholipids has been demon­
strated previously by Graham and Wood [24] They 
reported that treatment of microsomal preparations 
with phosphohpase A or С which attack specifically 
the membrane phospholipids, led to an mactivation 
ofLDPglucuronyltransferase Further studies done by 
Hanninen and Puukka [4] and Vessey and Zakim 
[5] revealed a severalfold increase in the rate of 
glucuronidation after a much milder treatment with 
phosphohpase A and С These authors concluded that 
the structure of the phospholipid environment in the 
membrane limits the maxima) activity of UDPglucur­
onyltransferase [11] The correspondence of the 
UDPglucuronyltransferase activation with the release 
of phospholipids from the microsomes, which we 
(bund after treatment with n-alkanes (see Table 4), 
is in good agreement with this concept n-Pen tane. 
which is the most active of the tested a I kanes in 
accelerating the glucuronidation rate, also caused the 
greatest release of phospholipids 
The treatment of the microsomal membranes with 
j7-alkanes increased the apparent Km values of U D P -
glucurotiate The same effect was observed for the 
phosphohpase treatment [4, 5], and after treatment 
with fatty acids [25] It was suggested that such alter­
ations in Km values must be ascribed to conforma­
tional changes m the microsomal proteins. Our find­
ings are consistent with this suggestion and, therefore, 
further support the idea that membrane phospho­
lipids have an important role in regulating U D P ­
glucuronyltransferase activity in the endoplasmic 
reticulum 
With reference to the mixed-function oxidase sys­
tem. it appeared that the n-alkanes exhibited a stimu­
latory effect on the rate of microsomal aniline p-
hydroxylation (Fig 1), whereas for the same con­
centrations the /V-demethylation of ammopynne was 
not influenced This strongly resembles the enhance­
ment of aniline /i-hydroxylation by acetone in rat 
liver microsomes [16 26] Acetone only activates the 
oxidation of compounds producing type H difference 
spectra Vaimo and Hanninen [16] concluded that 
the stimulatory effect of acetone may be explained 
in terms of a reversal of the inhibition of the cyto­
chrome P-450 reduction by aniline Our finding that 
u-heptane al a concentration which maximally stimu­
lates aniline ρ hydroxylalion enhanced the 
NADPH-cytochrome Ρ 450 reductase activity 
(Table 5) is in good agreement with their concept 
It should be emphasized that in contrast to acetone 
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π hepLinc (which appeared to produce a lype I differ 
enee чресігит wMh guinea-pig liver microsomes) as 
well as other type I substrates [ 17 J accelerated the 
reduction of cytochrome Ρ 450 
The present results as well as the data reported 
by Vainio and Hannmen [ 16] are dillicull to reconcile 
with the conclusions of Schenkman [ It)] and of Так 
eshige and M i n a k a m i [ 2 l ] that the reduction of 
cytochrome P-450 cannot be the rale limiting step 
in the oxidation of aniline Schenkman [ 10] suggested 
that aniline slows its own metabolism by inlerlènng 
with the oxygen activation by cylochroinc Ρ 450 
Further investigations arc needed in order to deter 
mine whether the η alkancs can counteract such an 
interference of the oxygen activation by aniline or 
whether the enhancement of the cslochrome P-450 
reduction by the presence of η alkancs accounts for 
the acceleration of the aniline oxidation 
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Alterations in the glucuronic acid pathway caused by 
various drugs 
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ABSTRACT 
1. Increased urinary and hepatic concentrations of u-glucuronic acid, L-ascorbic acid 
and D-glucanc acid were found within 8 hours after administration of sodium barbital, 
phénobarbital, nikethamide, DDT and chlorbutol to rats. No alterations in the urinary 
excretion of glucuromdes were observed. 
2. Administration of ethanol resulted within 8 hours in a significantly enhanced 
excretion of glucuromdes, whereas the glucuronic acid pathway was not stimulated. This 
suggests that stimulation of the glucuronic acid pathway and acceleration of glucuromde 
formation are not necessarily related. 
3. Treatment of rats with compounds capable of stimulating the glucuronic acid pathway 
did not influence the in miro activities of hepatic undine diphosphate glucose dehydro-
genäse and UDPglucuronyltransferase within 8 hours. 
4. The stimulative agents significantly enhanced both uridine diphosphate glucose 
(UDPG) and undine diphosphate glucuronic acid (UDPGA) concentrations m the liver. 
This suggests that stimulation of the glucuronic acid pathway is based on an enhanced 
availability of UDPG. 
As THE result of many studies, the glucuronic 
acid pathway, in which by a sequence of 
biochemical processes hexose is transformed 
via D-glucuronic acid to L-ascorbic acid, 
D-glucanc acid and D-xylulose, has been 
elucidated (Burns, Evans & Trousof, 1957; 
Ginsburg, Weissbach & Maxwell, 1958; 
Evans, Conney, Trousof & Bums, i960; 
Conney & Bums, 1961; Miettinen & 
Leskinen, 1970). The intermediate D-glu-
curonic acid as well as the end-products are 
found in the urine. 
In 1940 Longenecker, Fricke & King 
reported that various drugs administered to 
rats enhanced the urinary L-ascorbic acid 
excretion. Further investigations extended 
this phenomenon to other compounds and at 
the present time the stimulative influence is 
known of a large variety of xenobiotic agents 
(Burns & Evans, 1956; Burns et al. 1957; 
Conney & Burns, 1959; Conney, Bray, Evans 
& Burns, 1961). Many compounds which 
stimulate the glucuronate pathway also 
cause induction of the drug-metabolizing 
enzymes in the liver (Conney & Burns, 1959; 
Conney, Gillette, Inscoe, Trams & Posner, 
1959; Conney, 1967). Consequently, sugges-
tions that elevated urinary levels of L-
ascorbic and D-glucaric acid may be used as 
indicators of drug-induced alterations in the 
activity of drug-metabolizing enzymes have 
been proposed (Aarts, 1968a; Hunter, Max-
well, Stewart & Williams, 1972; Notten & 
Henderson, 1973, 1974). 
The mechanism by which drugs stimulate 
the glucuronic acid pathway is still uncertain. 
The diversity in chemical structures as well 
as in pharmacological properties makes it 
reasonable to suppose that a non-specific 
way exists by which those compounds 
exhibit their stimulative action. It is not 
known at which step in the sequence of 
enzymatic processes agents act on carbo-
hydrate metabolism, though from the results 
of several investigations tentative con-
clusions may be made. It is known that a 
glucose load in mice rapidly leads, via 
uridine diphosphate glucose (UDPG), to a 
strong increase of glycogen synthesis, due to 
an activation of glycogen-UDPglucosyltrans-
55 
ferase (Hers &. D e Wulf, 1968) I t i sapparent , 
however, that after treatment with drugs, 
D - [ I — I 4C]glucose and D - [ I — 1 4C]galactose 
are more rapidly converted into labelled 
D-glucuronic acid, L-gulonic acid and L -
ascorbic acid (Burns et al, 1957, Evans et al, 
1960, Conney et al, 1961 ) This is caused 
possibly by an increased channelling of 
D-glucose into the glucuronate pathway It 
has also been found that loading rats with 
near-precursors of L-ascorbic acid, eg D-
glucuronic acid and L-gulomc acid (lactone 
forms), resulted in enhanced L-ascorbic acid 
formation (Horowitz & King, 1953, Isher-
wood, Chen & Mapson, 1954, Burns & 
Evans, 1956) These data suggest that the 
stimulative eflect of drugs, resulting in 
enhanced L-ascorbic acid and D-glucaric acid 
synthesis, occur? before or at the stage o f 
glucuronic acid formation in the pathway 
t o r the conversion of uridine diphosphate 
glucuronic acid ( U D P G A ) into D glucuronic 
acid two main routes have been postulated 
(Evans, Gonney, Trousof & Burns, 1959, 
Pogell & Leloir, 1961, Miet tmcn & Leskmen, 
1963, Touster, iqöga.b) , namely a route via 
direct hydrolysis of U D P G A by a pyro-
phosphatase, and the UDPglucuronyltrans-
ferase route associated with the formation of 
glucuronides (see FIG I ) 
In the present investigation a further 
approach to the problem is made in deter-
mining the particular point in the glucuronic 
acid pathway at which the stimulative effect 
is initiated For that reason the influence of 
some exogenous compounds on the synthesis 
of D-glucuronic acid and its metabolic end-
products, as well as on the concentrations of 
U D P G and U D P G A in the liver was 
examined 
MATERIALS AND METHODS 
ANIMALS 
Male Wistar rats (Ratlus mrvegicus), weighing 
1 7 5 _ 2 3 0 S > were utilized AU animals w< re 
maintained on L-ascorbic acid-free Hope Farms 
Laboratory Diet, with free access to water I he 
agents were administered in two doses, at zero 
time and at 4 hours, as indicated in the tables 
Chlorbutol and DDT were given in an emulsion 
The D-galactosamine HCl solution was neutralized 
before application 
All compounds were administered ι ρ or ρ о 
(see tables) m salme Control «animals received 
saline in equivalent quantities 
Urine samples were collected in 10% oxalic acid 
solutions and stored at — 20° С until examination 
D-galactose O-giucose 
UDPG 
^ - N A D 
UDPG dehydrogenase 
^ N A D H 
UDPGA 
/ \ 
pyrophosphatase UOP gtucuronyl transferase 
D-glucuronic 
a c i d - l - phosphate 
X 
glucuronides 
β — glucuronidase 
D-glucuronic acid 
L- xylulose D-gluconc ocid L-ascorbic acid 
FIG 1 —The glucuronic acid pathway 
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LIVER PREPARATIONS 
The rats were decapitated 8 hours after the first 
drug application. The liver was removed and 
clamped between aluminium blocks cooled in 
liquid nitrogen (Wolltnberger, Ristau & SchofTa, 
1960). Portions of frceze-clamped liver tissue were 
weighed and finely mmced in ice using a Teflon-
glass Pottçr-Elvchjcm type homogemzcr. 
DFTERMINATION OF METABOI ITES IN THE LIVER 
UDPG and UDPGA were determined by slight 
modification of the methods of Mills & Smith 
(1965). Liver extracts (25%) wore prepared in 
ice-cold perchloric acid (final concentration 2% 
w/v). The determination of UDPG with UDPG-
dehydrogenase was based on the spectropholo-
metric measurement of NAD+ reduction. UDPGA 
was estimated by measuring the amount of 0-
aminophenyl glucuronide formed from UDPGA 
and o-aminophenol. 
After homogenizing liver ( 0 5 g ) with 4% tri-
chloroacetic acid (4-5 ml.), L-ascorbic acid was 
determined by the 2,4-dinitrophcnylhydrazine 
method (Schaftert & Kingsley, 1955). 
DETERMINATION OF METABOLITES IN THE URINE 
D-Glucanc acid was measured from the inhibitory 
effect of D-glucaro-(i)4)-lactone, to which it is 
converted by heating at pH 2, on /3-gluciironidase 
according to Marsh (1963). 
Dische's carbazole reaction, modified by Yuki 
& Fishman (1963) for differential analysis, was 
applied for the estimation of D-glucuronic acid 
and total glucuronidcs. 
L-Ascorbic acid was determined by the 2,4-
dinitrophenylhydrazine method (Schaffen & 
Kingsley, 1955). 
ENZYME ASSAYS 
For the determination of the UDPglucuronyl-
transferase activities, homogenates (25%, w/v) 
were prepared in о 25 M sucrose solution con­
taining 5 x io~a M tns-HCl (pH 7-4) and centn-
fuged for 20 minutes at 9000 c (2° C). After 
treatment of the supematants with Triton X-ioo 
( 0 2 5 % , final concentration). The activities 
were measured as reported earlier (Henderson, 
1970). p-Nitrophenol was used as acceptor 
substrate. 
UDPGdehydrogenase activities were measured 
at 38° С by following the rate of NAD + reduction 
spectrophotometncaJly at 340 nm. according to 
Strominger, Maxwell, Axelrod & Kalckar (1957). 
A portion of frozen liver was homogenized in 3 
volumes of 0-15 M KCl and subsequently centri-
fuged at 105,000; for 1 hour. The incubation 
mixture contained ο·2 ^mole UDPG, о 5 μπτοίε 
NAD and 0 0 2 ml. of the 105,000 g supernatant 
as enzyme source in a final volume of 1 ml. of 
ο·ι M glycine buffer (pH 8 7). 
Table I.- -EFFECT OF DRUGS ON THE URINARY EXCRETION AND LIVER CONTENT OF L-ASCORBIC 
ACID IN RATS 
TREATMENT 
Sodium barbital 
(150 mg/kg. i.p.) 
Phénobarbital 
( i3omg./kg. i.p.) 
Nikethamide 
(• ЗО mg./kg. i.p.) 
D-Galactosamine 
(600 mg./kg. i.p.) 
Control, i.p. 
Ethanol 
(5 g - t e ρ·»·) 
Chlorbutol 
(150 mg./kg. p.o.) 
D D T 
(60 mg./kg. p.o.) 
Control, (p.o.) 
(5) 
(6) 
(5) 
(6) 
(6) 
(6) 
(5) 
(5) 
(6) 
(mg./8 hour unne) 
2 · Ι 2 ± 0 31 
ι·8ι ± ο - ΐ 9 
9 - 6 i ± o g 4 
0-87 + О 22 
0 7 7 ± 0 I 3 
ι 33 ±0-32 
3·49±ο·97 
3 ·79±° ·22 
Ο 86 + 0-22 
L-ASCORBIC A C I D 
Ρ value 
< O-OOI 
<ο·οοι 
<ο·οοι 
>ο·θ5 
>ο·θ5 
>0·02 
<ο·θ5 
< ο ο ο ι 
(mg./g. fresh liver) 
0635 ± 0 0 3 4 
0-562 ± 0 0 1 1 
0 681 + 0-023 
0 211 ± 0 0 1 6 
0-505 ± 0-015 
0 392 ±0-016 
0-71310-031 
— 
0-590 + 0-032 
0 461 ± 0 039 
Ρ value 
>o-ooi 
<o-oi 
>o-oi 
< 0 02 
< o 001 
<o-ooi 
>ο·θ5 
<o-ooi 
>o-05 
< 0 02 
Collection of urine was started immediately after the first dose. 
Male rats (175-230 g.) were used. The compounds were given in 2 doses: at zero time and 4 hours. 
Controls received an equivalent volume of saline. 
The animals were killed at 8 hours. Values represent means + S.E.M. 
The numbers in parentheses represent number of animals per group. 
Ρ values were obtained by applying the Student /-test. 
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PROTEIN ASAY 
Amounts of protein were determined according 
to the method of Lowry, Rosebrough, Fair & 
Randall (1951). Bovine serum albumin was used 
as reference. 
RESULTS 
L-ASCORBIC ACID SYNTHESIS 
From the results given in Table I it is 
apparent that except for u-galactosamine, 
which is a known inhibitor of UDPG and 
UDPGA formation in vivo, and ethanol, all 
of the other compounds enhanced the liver 
content as well аз the urinary excretion of 
L-ascorbic acid. 
Ethanol neither influenced the amount of 
L-ascorbic acid present in the liver nor the 
L-ascorbic acid excretion. o-Galactosamine 
does not exhibit any measurable effect on 
urinary ascorbic acid excretion. From the 
strong decrease of the concentration in the 
liver it can be concluded that D-galactosamine 
counteracts the synthesis of L-ascorbic acid. 
URINARY D-GLUCARIC ACID EXCRETION 
As can be concluded from Table II, the 
urinary excretion of D-glucaric acid is 
influenced in the same way as the L-ascorbic 
Table III.—URINARY EXCRETION OF FREE AND CONJUGATED D-GLUCURONIC ACID IN RATS TREATED 
WITH VARIOUS COMPOUNDS 
D-GLUCURONIC ACID (mg./8 hour urine) 
TREATMENT 
Sodium barbital 
(i5omg./kg. i.p.) 
Phénobarbital 
(i30mg./kg. i.p.) 
Nikethamide 
(I30mg./kg. i.p.) 
D-Galactosamine 
(600 mg./kg. i.p.) 
Control, (i.p.) 
Ethanol 
(5 g-lbg. p.o.) 
Chlorbutol 
(150 mg./kg. p.o.) 
DDT 
(60 mg./kg. p.o.) 
Control, (p.o.) 
(5) 
(6) 
(5) 
(6) 
(6) 
(6) 
(5) 
(5) 
(6) 
Free 
i -6o±o- i5 
1 80 ± 0 3 5 
1-45 ± 0 3 0 
0-25 ±0-09 
0 6 5 ±0-15 
о-78 + о і б 
o-6i ± ο · ι ι 
Ι·30±0·02 
ο ·77±ο·ΐ4 
Ρ value 
>o-oa 
<ο·θ5 
>ο·οι 
< Ο Ό 2 
> ο ο ι 
<ο·05 
> 0 · 0 2 
< Ο · 0 5 
>ο·θ5 
> Ο · 0 5 
>Ο·ΟΟΙ 
<ο·οι 
Conjugated 
4 2 6 + 0 5 0 
3-58 +ο·25 
— 
4-27 + 0-37 
2-99 + 0· 11 
2-88 + 0-53 
8 ·6ι+ο·82 
4-28 + 0-7I 
3-02 + 0-29 
2·8ο + ο·3θ 
Ρ value 
>ο·θ5 
>ο·θ5 
> ο ο 5 
>0·05 
<0·0ΟΙ 
>ο·θ5 
>0·05 
Detaib are given in Table I. 
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acid excretion after the drug treatments. 
Unlike D-galactosamine and ethanol, which 
had no influence, the other compounds 
exhibit stimulatory effects on the excretion of 
D-glucaric acid. 
Table II.—URINARY EXCRETION OF D-X3LUCARIC 
ACID IN RATS TREATED WITH VARIOUS DRUGS 
TREATMENT 
Sodium barbital 
(150 mg./kg. i.p.) (5) 
Phénobarbital 
(130 mg./kg. i.p.) (6) 
Nikethamide 
(130 mg./kg. i.p.) (5) 
D-Galactosamine 
(600 mg./kg. i.p.) (6) 
Control, (i.p.) 
Ethanol 
(5 g./kg. p.o.) (6) 
Chlorbutol 
(150 mg./kg. p.o.) (5) 
DDT 
(60 mg./kg. p.o.) (5) 
Control, (p.o.) (6) 
D-GLUCARIC 
ACID 
(iig./B hour 
URINE) 
330 ± 36 
224 + 24 
272 ± 3 6 
I I 2 ± 8 
104+ 8 
4 9 ± 9 
135+14 
188 + 20 
9 5 ± β 
Detaib are given in Table I. 
Ρ value 
<ο·οοι 
< o-ooi 
> O-OOI 
<ο·οι 
>ο·θ5 
>o-05 
> 0 · 0 2 
<ο·θ5 
>ο-οοι 
<ο·οι 
URINARY EXCRETION OF FREE AND 
CONJUGATED D-GLUCURONIC ACID 
With respect to the precursors of D-
glucaric acid and L-ascorbic acid, it was 
evident that sodium barbital, phénobarbital, 
nikethamide and DDT enhanced the urinary 
excretion of o-glucuronic acid. 
The excretion of glucuronides is not 
influenced significantly by these compounds 
(Table III). Ethanol treatment strongly 
enhanced the excretion of glucuronides, 
whereas the excretion of D-glucuronic acid 
remained unchanged as is also the case after 
chlorbutol treatment. 
D-Galactosaminc significantly decreased 
D-glucuronic acid excretion. 
CONCENTRATION OF UDPG AND UDPGA 
IN THE LIVER 
The concentrations of UDPG and UDPGA 
were increased significantly after treatment 
with sodium barbital, phénobarbital, nik-
ethamide, chlorbutol and DDT. Ethanol did 
not exhibit any effect upon the UDPG and 
UDPGA levels, whereas D-galactosamine 
lowered the concentrations of these uridine 
nucleotides (Table IV). 
UDPGDEHYDROCENASE AND 
UDPGLUCURONYLTRANSFERASE AcnvmES 
In order to find out whether the observed 
alterations in the glucuronic acid pathway 
are related to an increase in enzyme activities, 
UDPGdehydrogenase and UDPglucuronyl-
transferase, with /i-nitrophenol as acceptor, 
were tested in vitro 8 hours after the first drug 
administration. The results are shown 
in Table V. It was apparent that the 
activities of these enzymes remained un-
changed. 
Further, it was established that no change 
in either total liver weight or microsomal 
protein content was produced by treatment 
with the various compounds. 
DISCUSSION 
The effects of the various exogenous com-
pounds on the glucuronate pathway are 
summarized in Table VI. It is seen that the 
synthesis of D-glucuronic acid, L-ascorbic acid 
and D-glucaric acid is increased significantly 
8 hours after the first application of sodium 
barbital, phénobarbital, nikethamide and 
DDT. Due to the enhanced levels of L-
ascorbic acid and D-glucaric acid, chlorbutol 
also may be considered as a stimulator of the 
glucuronic acid pathway, though no ex-
planation can be given as to why D-glucuronic 
acid excretion is not enhanced. Dayton, 
Vrindten & Perei (1964) have reported that 
in contrast to barbital, chlorbutol caused 
only a small increase of urinary D-glucuronic 
Table IV.—EFFECT OF VARIOUS COMPOUNDS ON UDPG AND UDPGA CONCENTRATION IN RAT LIVER 
TREATMENT UDPG „ . , UDPGA _ . , ((imoles/g. liver) ^ V A " > E (^moles/g. liver) ''VALUE 
Sodium barbital 
(i5omg./ig. i.p.) 
Phénobarbital 
( i3omg./kg. i.p.) 
Nikethamide 
( i somg. /kg. i.p.) 
D-Galactosaminc 
(600 mg./kg. i.p.) 
Control, (i.p.) 
Ethanol 
(5 g-/kg. P-o.) 
Chlorbutol 
(150 mg./kg. p.o.) 
DDT 
(60 mg./kg. p.o.) 
Control, (p.o.) 
(5) 
(6) 
(5) 
(6) 
(6) 
(6) 
(5) 
(5) 
(6) 
0-290 ±o-oao 
0370 ± 0 0 3 3 
0-443 ± 0 0 2 5 
0· 110 ±0-007 
0-232 ±0-019 
0-239 ± 0 0 1 9 
0-367 ± 0-039 
0-32910-028 
0-241 ± ο · ο ι ι 
>0-02 
<o-05 
<o-oi 
<o-ooi 
<o-ooi 
>0-o5 
<o-oi 
>o-oi 
<0-02 
0-500 ±0036 
0-687 ±0-017 
0-702 ±0-027 
о-і6о±о-оіз 
О-абі ±0-022 
o-igi +0-020 
0-360 ±0-040 
0 6 9 0 ± 0 0 4 0 
О-24О ± 0-021 
< 0-001 
< 0-001 
<o-ooi 
>0-O0I 
<0-0I 
>o-05 
>0-02 
<o-05 
<OOOI 
Details are given in Table I. 
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Table V.—EFFECT OF VARIOUS SUBSTANCES ON THE ІЯ vitra ACTIVI­
TIES OF HEPATIC UDPGDEHYDROGENASE AND UDPGLUCURONYL-
TRANSFERASE 
ΤІПРГ UDPGLUCURONI-
TREATMENT _ _ _ _ . . DATION OF 
DEHYDROGENASE· р .
М І т а о Р 1 І Е К О І . + 
Sodium barbital lo-go + o-ya 321 ± 0 1 7 
(i5omg./ltg. i.p.) (5) 
Phénobarbital ιο ·οο±ο·ι8 2 ·73±ο·ι ι 
(i3omg./kg. ¡.p.) (6) 
Nikethamide ιο ·82±ο·ι8 3-ΙΟ + ΟΌ4 
(i30mg./kg. i.p.) (5) 
D-Galactosamine 9-51 ± 0 1 2 3 - 07±o-25 
(600 mg./kg. i.p.) (6) 
Control, (i.p.) (6) 9-47 + 0-72 301 + 0 2 7 
Ethanol 10-91 ±1-26 3-40+0-29 
(5 nig-/bg· Ρ·θ·) (6) 
Chlorbutol 9-84+1-oo 3-08 ± 0 1 4 
(150 mg./kg. p.o.) ( 5 ) 
DDT ΙΟ-Ι6 + 0-68 2-71 ± 0 2 3 
(60 mg./kg. p.i.) (5) 
Control, (p.o.) (6) io-2i±o-75 2-94 + 0 1 3 
* Expressed an nmoles NADH formed per minute per mg. 
cytoplasmic protein. 
t Expressed as pmoles /i-nilrophenol conjugated per hour per 
mg. microsomal protein. 
For all values P> 0 0 5 (Student's Mest). Other details are given 
in Table I. 
Table VI.—SUMMARY OF THE EFFECTS OF SOME EXOGENOUS COMPOUNDS ON THE CLUCURONATE PATHWAY 
IN THE RAT 
UDPG 
(in liver) 
UDPGA 
(in liver) 
Glucuronides 
(in urine) 
D-Glucuronic acid 
(in urine) 
L-Ascorbic acid 
(in liver) 
L-Ascorbic acid 
(in unnc) 
D-Glucaric acid 
(in urine) 
UDPGdehydrogen­
ase 
UDPglucuronyl-
transferase 
SODIUM 
BARBITAL 
+ 
+ 
0 
+ + 
+ 
+ + 
+ + + 
0 
0 
PHÉNO-
BARBITAL 
+ 
+ + 
0 
+ + 
+ 
+ + 
+ + 
0 
0 
NIKETH-
AMIDE 
+ 
+ + 
0 
+ + 
+ 
+ + + 
+ + + 
0 
0 
CHLOR-
BUTOL 
+ 
+ 
0 
0 
+ 
+ + + 
+ 
0 
0 
DDT 
+ 
+ + 
0 
+ 
+ 
+ + + 
+ + 
0 
0 
ETHANOL 
0 
0 
+ + + 
0 
0 
0 
0 
0 
0 
D-GAL-
ACTOSAMINE 
— 
0 
— 
0 
0 
0 
0 
Details of the treatment are given in Tables I-V. (o) means not significantly changed; ( + ) elevated 
to 125-200 % of the control level ; ( + + ) 200-300 % of the control ; ( + + + ) more than 300 % of the 
control value, (—) significantly decreased. 
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acid levels; both compounds markedly en-
hanced L-ascorbic acid excretion. 
It is evident that neither the total glucuro-
nide excretion nor the in vitro rate of glucuro-
nidation of /i-nitrophenol was enhanced 
during the short-term treatments. This is in 
good agreement with the reports of Hollmann 
& Neubaur (1967), Zeidenberg, Orrenius & 
Ernster (1967) and Aarts (1968b). In con-
trast, ethanol treatment resulted within 8 
hours in an enhanced glucuronide excretion, 
whereas the glucuronic acid pathway is not 
stimulated. This might be ascribed to an 
increased substrate supply to the enzyme 
system, or to an activation of UDPglucuronyl-
transferase m vivo, as has been found recently 
in guinea-pigs shortly after administration of 
a single dose of n-hexane (Notten & Hender-
son, 1374). 
From these data it may be concluded that 
stimulation of the D-glucuronate pathway 
and accelerated glucuronidation are not 
directly related. 
Earlier it has been postulated (Hollmann 
& Neubaur, 1967) that the stimulative 
effects of drugs on the D-glucuronate pathway 
might be due to an enhanced formation of 
UDPGA as the result of a drug-induced di 
novo synthesis of UDPGdehydrogenase. 
Chlorbutol, barbital (Hollmann & Touster, 
1962) and chloroquine (Arias, Gartner, 
Furman & Wolfson, 1963), indeed appeared 
to cause an enhanced UDPGdehydrogenase 
activity after a treatment period of several 
days. However, from the experiments of 
Aarts (1968b) and Hollmann & Neubaur 
(1967) it appeared that, although barbital 
and chlorbutol treatment leads to an increased 
urinary L-ascorbic acid excretion within 24 
hours, the in vitro UDPGdehydrogenase 
activity is not enhanced in this period. Our 
results also demonstrate that treatment of 
rats with drugs for 8 hours does not elevate 
the in vitro activity of UDPGdehydrogenase, 
whereas stimulation of the glucuronic acid 
pathway is evident. Therefore, it is con-
cluded that a stimulation of the glucuronic 
acid pathway shortly after administration of 
the drugs is independent of an induction of 
UDPGdehydrogenase. 
With respect to the mechanism of stimu-
lation it is important that the stimulative 
agents tested significantly enhance both 
UDPG and UDPGA concentrations in the 
liver (Tables IV and VI). The most plausible 
conclusion therefore is that stimulation of the 
glucuronic acid pathway is primarily based 
on an enhanced availability of UDPG in the 
liver cell. This conclusion is further confirmed 
by the experiments with o-galactosamine. 
Besides a lowered UDPG and UDPGA level 
in the liver, D-galactosamine also leads to 
both a decreased urinary excretion of D-
glucuronic acid and and a decreased L-
ascorbic acid liver content. The fact that 
urinary L-ascorbic acid and D-glucaric acid 
excretion are not decreased within 8 hours 
after the first administration could be due to 
a repletion effect of these metabolites in the 
organism. 
The mechanism by which the exogenous 
compounds elevate the UDPG level in the 
liver still remains obscure. Possibly, drugs 
stimulating the glucuronic acid pathway 
inhibit glycogen synthesis so that more 
UDPG becomes available for the UDPGA 
production. This consideration is supported 
by the finding of Jones & Fawcett (1966) that 
treatment of animals with phénobarbital 
results in a considerable reduction in glycogen 
particles associated with the smooth mem-
branes of the liver cell. 
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Abstract 
1. Administration of phénobarbital to suspensions of isolated rat hepatocytes 
resulted within 90 min in an enhanced synthesis of D-glucaric acid, L-ascor-
bic acid and uridine disphosphate glucuronic acid (UDPGA). 
2. No alterations in the in vitro activities of UDPGdehydrogenase and UDP-
glucuronyltransferase were found within 120 min after treatment of the 
cells with phénobarbital. 
3. At increasing phénobarbital concentrations the uridine diphosphate 
glucose (UDPG) level increased significantly whereas a decrease in the gly-
cogen concentration occurred. 
4. C'^labeling experiments showed a lower rate of D-glucose-1-C14 incorpora-
tion in glycogen (expressed as per mg protein) of phénobarbital treated 
cells, whereas an equal increase in specific activities as a function of time 
was observed in both phénobarbital treated and control cells. This strongly 
suggests that the lowered glycogen concentration, after treatment with 
phénobarbital, is caused by a decreased synthesis of glycogen, resulting in 
an enhanced availability of UDPG. 
On account of these results it has been concluded that a stimulation of the 
D-glucuronic acid pathway most probably is based on an inhibition of gly-
cogen synthesis. 
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Introdactìon 
As well as exhibiting a stimulatory effect on the microsomal enzymes, involved 
in the metabolism of drugs and other body foreign compounds, many xeno-
biotics may frequently influence the metabolism of normal body constituents 
(Conney, 1967). One example is the accelerated hepatic carbohydrate meta-
bolism via the glucuronic acid pathway after exposure to body-foreign com-
pounds. In this pathway hexose is converted via UDPG, LJDPGA and D-glucu-
ronic acid into L-ascorbic acid, D-glucaric acid and L-xylulose respectively 
(Bums and Evans, 1956; Burns, Evans and Trousof, 1957; Conney and Burns, 
1959; Conney, Bray, Evans and Burns, 1961). It has been suggested, therefore, 
that enhanced levels of L-ascorbic acid and D-glucaric acid can serve as an 
indication of exposure to xenobiotic compounds (Conney, 1967; Aarts, 1968; 
Okada, Matsui, Kaisu and Abe, 1969; Hunter, Maxwell, Stewart and Williams, 
1973; Notten and Henderson, 1973; 1975). 
The mechanism by which xenobiotic compounds stimulate the glucuronic acid 
pathway has not been fully elucidated. The results of Burns and Evans (1956), 
Conney, Bray, Evans and Burns (1969) and Evans, Conney and Bums (1960) 
suggest that this stimulatory effect is initiated in the pathway before or at the 
stage of glucuronic acid synthesis. Since our previous work (Notten and Hen-
derson, 1975) has indicated that stimulative agents also enhance both UDPG 
and UDPGA levels in the liver, it was concluded that stimulation of the glucu-
ronic acid pathway is primarily based on an enhanced availability of UDPG. 
However, the way in which exogenous compounds enhance the UDPG concen-
tration is still unknown. It has been suggested (Notten and Henderson, 1975), 
that xenobiotic compounds may stimulate the glucuronic acid pathway by 
inhibiting glycogen synthesis from UDPG so that more UDPG becomes avail-
able for the UDPGA production. This suggestion is also in agreement with the 
experiments of Jones and Fawcett (1966) who found that treatment of 
hamsters with phénobarbital, a well known stimulator of the glucuronic acid 
pathway, resulted in a considerable depletion of glycogen particles associated 
with the hepatic agranular endoplasmic reticulum. 
The purpose of the present study was to establish whether or not a stimula-
tion of the glucuronic acid pathway is based on an inhibition of glycogen syn-
thesis. Therefore, the effect of phénobarbital on the synthesis of glycogen and 
some metabolites of the glucuronic acid pathway, such as UDPG, UDPGA, 
D-glucuronic acid, L-ascorbic acid and D-glucaric acid, was investigated in 
intact parenchymal cells which were isolated from rat liver. 
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Methods 
Animals 
Male Wistar rats (Rattus norvégiens), weighing 275-325 g were utilized. The 
animals were fed ad libitum except during a 16-20 hr fasting period prior to the 
experiments, and had free access to water. 
Liver cell isolation and incubation 
Suspensions of rat liver cells were prepared according to the method described 
by Seglen (1973a), with slight modifications. After purification (removal of cell 
debris and non-parenchymal cells) of the parenchymal cell suspensions by dif-
ferential centrifugation, the cells were finally suspended at a concentration of 
12-13.106 cells/ml (120-130 mg wet weight/ml) in an oxygen saturated buffer, 
pH 7.6, containing: 4.0 g NaCl, 0.4 g KCL, 0.15 g КНгРО* 0.1 g N a ^ O * 
0.13 g MgCl2. 6 H 2 0 , 0.18 g CaClj. 2 H 2 0, 7.2 g HEPES (W-2-hydroxyethyl-
piparazine-JV^-ethanesulfonic acid), 6.9 g TES CiV-Tris-(hydroxymethyl)-
methyl-2-aminoethanesulfonic acid), 6.5 g Tricine (N-Tris-(hydroxymethyl)-
methylglycine), 2.1 g NaOH and H 2 0 ad 1000 ml. The cell suspensions were 
preincubated for 5 min at 370C. Thereafter 3 ml samples were pipetted into 15 
ml tubes together with glucose (final concn. 70 mM), and various quantities of 
phénobarbital (total volume 3.9 ml). The air in the glass stoppered tubes was 
replaced by a mixture of O2 (95%) and CO2 (5%) and incubation was carried 
out in a rotary shaker at 370C. 
Analytical Methods 
After incubation the tubes were cooled in liquid nitrogen (5 sec) and centri-
fuged immediately for 45 sec at 900 g. The supernatants were quickly decanted 
and the pellets were frozen by immersion of the tubes in liquid nitrogen. 
Simultaneously, 2 ml of 3% perchloric acid was added. The cell pellets were 
homogenized with a Teflon-glass Potter Elvehjem type of homogenizer at 0°C. 
After centrifugation at 15000 g (20 min, 40C). concentrations of UDPG, 
UDPGA and glycogen were measured in the supernatant. 
UDPG was determined according to the method of Mills and Smith (1965), 
where the presence of UDPGdehydrogenase is monitored by spectrophoto-
metric measurement of NAD* reduction. 
For the assay of UDPGA the procedure of Zhivkov (1970, 1972) was used 
with some exceptions. Nucleotides were first isolated by shaking the crude 
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liver cell extract with acid-washed Norit A (final concn. 1% w/v) for 10 min 
and allowed to stand for 20 min at 4°C. After purification (two times) of the 
charcoal by centrifugation and resuspension in water, the final Norit pellet 
was resuspended in 10% (v/v) of freshly distilled pyridine in 50% (v/v) ethanol. 
Elution was allowed to proceed over a 2 h period at 37°C, with occasional 
shaking. The charcoal was separated by centrifugation and the supematants 
evaporated to dryness at room temperature. The residues were dissolved in 
water (0.1 ml) and chromatographed on Whatman 3 MM paper. The chro-
matogram was developed with isobutyric acid/water/aqueous ammonia (44/ 
22/1, by volume) for 44 h at room temperature. The spots containing UDPGA 
were cut out and eluted with water for at least 8 h. UDPGA was assayed 
spectrophotometrically at 262 nm. 
Glycogen was subsequently precipitated from the perchloric acid extract by 
ethanol according to the method of Walaas and Walaas (1950), redissolved in 
water and enzymatically hydrolyzed. The incubation system consisted of: 
0.3 ml glycogen solution, 2 units of amyloglucosidase (E.C. 3.2.1.33,a-1,4, 
a-l,6-glucan glucohydrolase), in a final volume of 0.5 ml of 0.02 M acetate 
buffer (pH 4.7). After incubation for 20 min at 550C the glucose released was 
analyzed by glucose oxidase (E.G. 1.1.3.4,/î-D-glucose: O2 oxidoreductase). 
After sonicating the cell suspensions, to which 6% trichloracetic acid (1.5 
volume) was added, for 20 sec with an ultrasonic disintegrator (MSE-100 
Watt), L-ascorbic acid was determined by the 2,3-dinitrophenylhydrazine 
method (Schaffert and Kingsley, 1955). 
D-glucaric acid was measured from the inhibitory effect of D-glucaro-(l,4)-
lactone, to which it is converted by heating at pH 2.0, on /}-glucuronidase, 
according to Marsh (1963). For this purpose the cell suspensions (1.5 ml) were 
subsequently heated in a boiling water bath for 15 min, cooled to 0°C and 
sonicated for 20 sec. After centrifugation the supernatant was used for the 
D-glucaric acid assay. 
Amounts of protein were determined according to the method of Lowry, 
Rosebrough, Farr and Randall (1951). Bovine serum albumin was used as 
reference. 
Incorporation ofD-glucose-l-C1* into UDPGA and glycogen 
D-glucose-l-Cu, 3 mCi/mmole, was obtained from the Radiochemical Centre, 
Amersham, England. The isotope (2 jiCi/ml) was added to the cell suspension 
after the suspension was incubated for 60 min with 70 mM glucose in the pre-
sence or absence of 1.0 mM of phénobarbital. The incubation was stopped at 
specific times, samples were taken and UDPGA and glycogen were isolated as 
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described above. Aliquots of the respective samples were pipetted into scintil­
lation vials containing 10 ml of Instagel (Packard) and counted in a Packard 
Tricarb L С model 3380 liquid scintillation counter. 
Enzyme assays 
For the in vitro determination of enzyme activities the liver cells (3 ml suspen­
sions) were centrifuged, washed twice and homogenized in 0.15 M KCl (2.0 
ml) with a Teflon-glass Potter-Elvehjem type of homogenizer. After centrifu-
gation of the crude homogenates at 9000 g for 20 min the supernatants were 
centrifuged in a Christ Omega II Ultracentrifuge at 105.000 g for 1 h (20C). 
After freezing the pellets for 20 h at — 1 5 ^ , the microsomal pellets from the 
latter step were gently resuspended in the homogenization medium with the 
Potter-Elvehjem apparatus. 
UDPglucuronyl transferase activities were measured in the microsomal pre­
parations as reported earlier (Henderson, 1970), except sonication. p-Nitro-
phenol was used as an acceptor substrate. 
UDPGdehydrogenase activities were measured in the 105.000 g supernatants 
by following the rate of NAD* reduction spectrophotometrically at 340 nm 
according to the procedure of Strominger, Maxwell, Axelrod and Kalckar 
(1957). 
Results 
Synthesis ofL-ascorbic acid andD-glucaric acid 
From the data in fig. 1, it is evident that administration of phénobarbital to 
liver cell suspensions results in an enhanced synthesis of L-ascorbic acid and 
D-glucaric acid. The production of both metabolites increased with the 
amount of phénobarbital in the cell suspension. 
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FIG. 1. 
The influence of phénobarbital on the synthesis of L-ascorbic acid and D-glucaric acid 
in isolated parenchymal cells from rat liver. Cell suspensions were incubated for 90 min 
with the various phénobarbital concentrations. Circles represent means (± 2 S.E.M.) 
for 4 experiments. Significantly different from the control at: " 0.02 < Ρ < 0.05; "0.001 
< Ρ < 0.001 ; "" Ρ < 0.001 ; for all other values Ρ > 0.05 (Student's t-test). 
Concentration ofUDPG and UDPGA 
Comparable with the effect of phénobarbital on the synthesis of the end-
products of the glucuronic acid pathway, the UDPG level increased signif-
icantly at increasing phénobarbital concentrations (fig. 2). The UDPGA con-
centration remained unchanged after treatment of the cell suspensions with 
various amounts of phénobarbital (fig. 3). In spite of these data we examined 
the possibility that, after treatment with phénobarbital, the enhanced avail-
ability of UDPG may still lead to an increased synthesis of UDPGA which, 
due to a proportional enhanced turn over, finds no expression in an enhanced 
level. Therefore, the rate of D-glucose-l-Cu incorporation into UDPGA in 
liver cells was studied. As is illustrated in fig. 4, phénobarbital treatment 
clearly leads to a more rapid labelling of UDPG A which indicates an enhanced 
rate of UDPGA synthesis. 
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FIG. 2. 
Effect of phénobarbital on the UDPG concentration in isolated parenchymal rat liver 
cells. Cell suspensions were incubated for 90 min with the various phénobarbital con-
centrations. Circles represent means (± 2 S.E.M.) for 4 experiments. Significantly dif-
ferent from the control at: "0.02 >P >0.01; "0.01 > Ρ >0.001 (Student's t-test). 
FIG. 3. 
Effect of phénobarbital on the UDPGA concentration in isolated parenchymal cells 
from rat liver. Cell suspensions were incubated for 90 min with the various phéno-
barbital concentrations. Circles represent means (± 2 S.E.M.) for 4 experiments. For 
all values Ρ >0.05 (Student's t-test). 
FIG. 4. 
The influence of phénobarbital on the rate of UDPGA labelling in isolated liver cells. 
after administration of uC-glucose. 14C-glucose was added to the cell suspensions after 
preincubation for 60 min in the presence » » or absence о о of 1.0 mM phé-
nobarbital. 
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Glycogen content and synthesis 
Due to the fact that the liver cells were isolated after a 16-20 h fasting period, 
glycogen levels were almost undetectable at the beginning of the experiments, 
whereas these cells retained a high glycogen synthetic capacity. This is appa-
rent from the presence of a considerable amount of glycogen after 90 min in-
cubation of the cells with glucose. As is illustrated in fig. 5, incubation in the 
presence of phénobarbital resulted in a much lower glycogen concentration 
when compared with the control. Fig. 6 shows that our experimental condi-
tions support a rather constant rate of glycogen accumulation for at least 120 
min, both in the absence and presence of phénobarbital. 
glycogen 
fag/mg protein) 
12.0 π 
6.0-
4.0 
0 0.5 1.0 
phenobarbitc»! ( m M ) 
FIG. 5. 
Effect of phénobarbital on the glycogen concentration in isolated parenchymal cells 
from rat liver. Cell suspensions were incubated for 90 min with the various phénobar-
bital concentrations. Each value represents the mean ± 2 S.E.M. for 4 experiments. 
" Indicates significantly different from the control at Ρ < 0.001 (Student's t-test). 
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FIG. 6. 
Time course of the glycogen level in isolated liver cells during incubation with 
• · or without о o l.OmM phénobarbital. 
In order to determine whether the lowered glycogen concentration was due 
to a decreased synthesis of glycogen we studied the incorporation of D-glucose-
1-C14 into glycogen in phénobarbital (1.0 mM) treated and untreated cell cul-
tures. The phénobarbital treated cells exhibited a lower rate of C u incorpora-
tion into glycogen as compared with the control (expressed as per mg protein) 
(fig. 7). However, the observed equal increase in specific activities as a func-
tion of time (fig. 7) indicates that the lowered incorporation of D-glucose-1-
C14, after phénobarbital treatment, most probably is caused by a decreased 
synthesis of glycogen, which is the result of an inhibition of the glycogen syn-
thetase (UDPgIucose-a-l,4-glucan α-4-glucosyltransferase; E.C. 2.4.1.11) 
activity. 
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FIG. 7. 
Time course of glycogen labelling in rat liver cells after administration of 14C-glucose. 
14C-glucose was added to the cell suspensions after a preincubation period of 60 min in 
the presence · · or о о absence of 1.0 mM phénobarbital. 
UDPGdehydrogenase and UDPglucuronyltransferase 
Activities of UDPGdehydrogenase and UDPglucuronyltransferase, with 
p-nitrophenol as acceptor, were tested in vitro after treatment of the liver cells 
with 1.0 mM phénobarbital for 120 min. As can be seen in Table I, none of the 
activities were affected by phénobarbital. 
Microsomal protein content 
The total protein content was found to be 1.67 mg per 106 cells. Treatment 
with phénobarbital did not measurably change the microsomal protein con-
tent in the liver cells (table I). 
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TABLE I 
Effect of phénobarbital pretreatment on microsomal protein content and the in 
vitro activities of UDPglucuronyltransferase and UDPGdehydrogenase 
UDPG-
dehydrogenase*** 
7.68 ±0.28 
7.20 ± 0 47 
Rat liver cell suspensions were treated with 1.0 mM phénobarbital for 120 mm. Values re-
present means ± 2 S.E.M. Numbers in parentheses represent the number of animals per group. 
For all values Ρ > 0.05 (Student's t-test). 
* Expressed as mg per g isolated liver cells. 
** Expressed as Mmolesp-mtrophenol conjugated per hr per mg microsomal protein. 
*** Expressed as nmoles NADH produced per mm per mg protein present in the 105000 g 
supernatant fraction. 
Discussion 
The results demonstrate that phénobarbital is able to activate the synthesis of 
L-ascorbic acid and D-glucaric acid in isolated rat hepatic cells within 90 min 
(fig. 1). Recently, we found a similar stimulative effect within 8 hours after 
administration of phénobarbital and other stimulative drugs to rats (Notten 
and Henderson, 1975). It was concluded that a stimulation of the glucuronic 
acid pathway, within 8 hours, is independent of the induction of neither 
UDPGdehydrogenase nor UDPglucuronyltransferase as had been suggested 
by Hollman and Touster (1962). It seems reasonable to assume that a stimula-
tion of the glucuronic acid pathway, in isolated rat liver cells within 90 min, is 
also independent of an induction of UDPGdehydrogenase and UDPglucuro-
nyltransferase. In fact, we tested the in vitro activities of both enzymes. As 
expected, neither of the enzyme activities were significantly elevated within the 
treatment period (table I). Corresponding to the results from earlier in vivo 
experiments, mentioned above, an enhanced UDPG concentration in phéno-
barbital treated cells was found within 90 min (fig. 2), concomitant with an 
increased synthesis of UDPGA (fig. 4). Thus, it is justifiable to conclude that 
stimulation of the glucuronic acid pathway in liver cell suspensions is, as in 
vivo, primarily based on an enhanced availability of UDPG. The UDPG con-
tent of the control cells (0.07 ^ o l e s / g liver cells) was about 3-4 fold lower 
than that of normal liver (0.24 ^moles/g liver; Notten and Henderson, 1975). 
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Treatment Microsomal UDPglucuromdation 
protein* of p-mtrophenor* 
Control (4) 29.27 ±2.10 0.55 ± 0.03 
Phénobarbital (4) 33.82 ±1.81 0.53 ± 0.02 
A strong diminution of the hepatic level of UDPG was also found by Hers and 
De Wulf (1968), in both fed and fasted mice, after the intravenous administra­
tion of a glucose load, together with a stimulation of glycogen synthesis. These 
authors concluded that the activation of glycogen synthetase, due to the glu­
cose load, was responsible for these effects. To obtain a maximal rate of gly­
cogen synthesis we incubated liver cells, which possessed a very low initial gly­
cogen level, with 70 mM glucose (Seglen, 1973b). It is therefore probably that 
the low cellular UDPG level is due to an enhanced glycogen synthetase 
activity. 
Bauer and Reutter (1973) extrapolated, from their Lineweaver-Burk plots, 
a Km value of 2.0.ΙΟ"5 M UDPG for rat liver UDPGdehydrogenase. This value 
is only 3.5 fold lower than the UDPG concentration measured in isolated liver 
cells. In view of this fact, the simultaneously enhanced synthesis of UDPGA 
and an increased availability of UDPG in the liver cells can be related. In 
vivo an enhanced UDPG level in the livers of rats, treated with stimulative 
agents is also accompanied with an increased synthesis of UDPGA (Notten 
and Henderson, 1975). This occurs in spite of a much higher UDPG concen­
tration which, in control livers, is about 10-fold higher than the Km value of 
UDPG. A possible explanation for this discrepancy may be due to compartmen-
tation of UDPG in the cell, so that UDPG concentration in the various pools 
may vary substantially. 
The reason why a stimulation of the glucuronic acid pathway did not lead to an 
enhanced UDPGA concentration (fig. 3), as we found in rat liver, may be due to 
a much lower UDPG concentration in isolated cells as compared to rat liver. In 
the former case the conversion of UDPGA is not rate-limiting. 
With respect to the mechanism by which phénobarbital stimulates the glucuro-
nic acid pathway it is evident that a simultaneous decrease of the glycogen 
concentration occurred (fig. 5). However, at increasing phénobarbital concen-
trations the UDPG level significantly increasing. The incorporation 
experiments demonstrated that the decrease of glycogen most likely is caused by 
a decreased glycogen synthetase activity, which results in an enhanced availabi-
lity of UDPG (fig. 7). Therefore, it may be concluded that a stimulation of the 
glucuronic acid pathway is the result of an inhibition of glycogen synthesis. Gly-
cogen synthetase has been reported to be present in two interconvertable 
forms; the D or inactive form which is dependent on glucose 6-phosphate and 
the I, or active form, which is glucose 6-phosphate independent (Roseli-Perez, 
Villar-Palasi and Larner, 1962; Friedman and Lamer, 1963; De Wulf and 
Hers, 1968a.b.c). it cannot be excluded that phénobarbital acts by inducing 
the conversion of glycogen synthetase I into D, and is responsable for the 
observed inhibitory effect on glycogen synthesis in the liver cells. 
77 
Acknowledgements 
The authors are indebted to Professor Dr. E.J. Ariens, Institute of Pharmacology, 
University of Nijmegen, for helpful suggestions and criticism in this study. We grate­
fully acknowledge the technical assistance of Miss J.M.T. Hoog Antink and Mr. 
H.Th.H. van Aanholt. Financial support was obtained from the Praeventiefonds. 
References 
1. Aarts, E.M. (1968), Drug-induced stimulation of the glucuronic acid system, Ph.D. 
Thesis, Drukkerij Gebr. Janssen, N.V., Nijmegen, The Netherlands. 
2. Bauer, С. and Reutter, W. (1973), Inhibition of uridine diphosphoglucose dehydro­
genase by galactosamine-1 -phosphate and UDP-galactosamine, Biochim. biophys. 
Acta, 293, 11-14. 
3. Burns, J.J., and Evans, С (1956), The synthesis of L-ascorbic acid in the rat from 
D-glucuronolactone and I^-gulonolactone, J. BioL Chem. 223, 897-905. 
4. Burns, J.J., Evans, С and Trousof, N. (1957), Stimulatory effect of barbital on 
urinary excretion of L-ascorbic acid and nonconjugated D-glucuronic acid, J. Biol. 
Chem. 227, 785-794. 
5. Conney, A.H. (1967), Pharmacological implications of microsomal enzyme induc­
tion, Pharmac. Rev. 19. 317/366. 
6. Conney, A.H., Bray, G.A., Evans, С and Burns, J.J. (1961), Metabolic interactions 
between L-ascorbic acid and drugs, Ann. N. Y. Acad. Sci. 92,115-127. 
7. Conney, A.Ht and Burns, J.J. (1959), Stimulatory effect of foreign compounds on 
ascorbic acid biosynthesis and on drug-metabolizing enzymes, Nature 184, 
363-364. 
8. Evans, C , Conney, A.H., Trousof, N. and Burns, J.J. (1960), Metabolism of 
D-galactose to D-glucuronic acid, L-gulonic acid and L-ascorbic acid, Biochim. 
biophys. Acta 41, 9-14. 
9. Friedman, D.L., and Lamer, J. (1963), Studies on UDPG-a-glucan transgluco-
sylase. Biochemistry 2, 669-675. 
10. Henderson, P.Th. (1970), Activation in vitro of rat hepatic UDPglucuronyltrans-
ferase by ultrasound,Life Sci. Partii, 9, 511-518. 
11. Hunter, J., Maxwell, J.D., Stewart, D.A. and Williams, R. (1972), Increased 
hepatic enzyme activity from occupational exposure to certain organochlorine 
pesticides. Nature 237, 399-401. 
12. Jones, A.L. and Fawcett, D.W. (1966), Hypertrophy of the agranular endoplasmic 
reticulum in hamster liver induced by phénobarbital. J. Histochem. Cytochem. 14, 
215-232. 
13. Lowry, O.H., Rosebrough, N.J., Fair, A.L. and Randall, R.J. (1951), Protein 
measurement with the Folin phenol reagent,/. Biol. Chem. 193, 265-275. 
14. Marsh, C.A. (1963), Metabolism of D-glucuronolactone in mammalian systems, 
Biochem. J. 87. 82-90. 
78 
15. Mills, G.T. and Smith, E.E.B. (1965), in: Methods of enzymatic analysis (ed. Berg­
meyer, H.H.), pp. 581-595, New York: Academic Press. 
16. Notten, W.R.F. and Henderson, P.Th. (1973), Effect of disulfiram on the urinary 
D-glucaric acid excretion and activity of some enzymes involved in drug metab­
olism in guinea-pig. Arch. int. Pharmacodyn. 205, 199-208. 
17. Notten, W.R.F. and Henderson, P.Th. (1975), The influence of n-hexame treat­
ment on the glucuronic acid pathway and activity of some drug-metabolizing 
enzymes in guinea-pig, Biochem. Pharmac. 24, 127-131. 
18. Notten, W.R.F. and Henderson, P.Th. (1975), Alterations in the glucuronic acid 
pathway caused by various drugs. Int. J. Biochem. 6,111-119. 
19. Okada, M., Matsui, M., Kaizu, T. and Abe, F. (1969), Studies on the glucaric acid 
pathway in the metabolism of D-glucuronic acid in Mammals, Chem. Pharm. 
Bull. 17,2625-2628. 
20. Roseli-Perez, M., Villar-Palasi, С and Lamer, J. (1962), Studies on UDPG-gly-
cogen transglucosylase, Biochemistry, 1, 763-768. 
21. Schaffert, R.R. and Kingsley, G.R. (1955), A rapid, simple method for the deter­
mination of reduced, dehydro-, and total ascorbic acid in biological material, 
J. Biol. Chem. 212. 59-68. 
22. Seglen, P.O. (1973*), Preparation of rat liver cells, ExptL Cell Res. 82, 391-398. 
23. Seglen, P.O. (1973b), Glycogen synthesis in isolated parenchymal rat liver cells, 
FEBS Letters 30. 25-28. 
24. Strominger, J.L., Maxwell, E.S., Axelrod, J. and Kalckar, H.M. (1957), Enzymatic 
formation of uridine diphosphoglucuronic acid, J. Biol. Chem. 224, 79-90. 
25. Walaas, O. and Walaas, E. (1950), Effect of epinephrine on rat diaphragm,/. BioL 
Chem. 187. 769-776. 
26. De Wulf, H. and Hers, H.G. (19684 The influence of inorganic phosphate, 
adenosine triphosphate and glucose-6-phosphate on the activity of liver glycogen 
synthetase, European J. Biochem. 6, 545-551. 
27. De Wulf, H. and Here, H.G. (1968b), The interconversion of liver glycogen synthe­
tase a and b in vitro, European J. Biochem. 6, 552-557. 
28. De Wulf, H. and Hers, H.G. (1968<0, The role of glucose, glucagon and glucocorti-
cocoids in the regulation of liver glycogen synthesis. European J. Biochem. 6, 558-
564. 
29. Zhivkov, V. (1970), Measurement of uridine diphosphate glucuronic acid concen­
trations and synthesis in animal tissues, Biochem. J. 120, 505-508. 
30. Zhivkov, V. (1972), Measurement of the relative rates of synthesis of uridine 
diphosphate sugars in some tissues of vertebrates by using (l-^Qglucose, Int. J. 
Biochem. 3, 258-264. 
Key words 
D-glucuronic acid pathway 
UDPG 
UDPGA 
L-ascorbic acid 
79 
D-glucaric acid 
UDPGdehydrogenase (EC 1.1.1.22) 
UDPglucuronyltransferase (EC 2.4.1.17) 

Summary 
Alterations in the D-glucuronic acid pathway and the activities of some 
enzymes involved in the metabolism of compounds foreign to the body, under 
the influence of xenobiotic compounds, are the subject of this study. Major 
attention is paid to the evaluation of the urinary excretion of D-glucaric acid 
as a reliable nonspecific test for diagnosing exposure to exogenous com-
pounds as well as the drug-metabolic capacity of the liver. The mechanism by 
which drugs stimulate the D-glucuronic acid pathway, in which D-glucaric 
acid is synthesized, is also strongly emphasized in this project. The main results 
of this series of studies are listed here briefly. 
Experiments in which animals are chronically treated with very low subtoxic 
doses of various compounds, as well as short-term experiments demonstrate 
the usefulness of an altered urinary D-glucaric acid level as a nonspecific indi-
cator for exposure to xenobiotic compounds. This conclusion is further sup-
ported by the results of some preliminary investigations in which workers in 
the chemical industry were tested for their urinary D-glucaric acid level. 
Great discrepancies were found between the effect of a number of xeno-
biotic compounds on the urinary D-glucaric acid excretion and their influence 
on the activities of some drug-metabolizing enzymes. Due to these discrepan-
cies it is concluded that the urinary D-glucaric acid level is not necessarily 
related to the extent of the drug-metabolizing capacity of the liver. 
It has further been demonstrated that in the cases of short-term treatment a 
stimulation of the D-glucuronic acid pathway is independent of an induction 
of UDPGdehydrogenase. The results strongly suggest that a stimulation of the 
D-glucuronic acid pathway is based on an enhanced availability of UDPG in 
the liver cell which, in turn, is the result of an inhibition of glycogen synthesis. 
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Samenvatting 
In dit onderzoek werden de door xenobiotica veroorzaakte veranderingen in 
het D-glucuronzuursysteem en in de activiteiten van enige enzymen, betrok-
ken bij het metabolisme van lichaamsvreemde stoffen, bestudeerd. Centraal 
hierbij stond de evaluatie van de excretie van D-glucaarzuur, één der eindpro-
dukten van het D-glucuronzuursysteem, in de urine als een betrouwbare, aspe-
cifieke test voor de diagnose van blootstelling aan exogene stoffen als ook voor 
de farmacon-metabole kapaciteit van de lever. Tevens werd tijdens dit onder-
zoek aandacht geschonken aan het stimuleringsmechanisme van het D-glucu-
ronzuursysteem door xenobiotica. De belangrijkste resultaten uit deze studie 
zijn hier kort samengevat. 
Zowel experimenten waarin dieren chronisch werden behandeld met zeer lage, 
subtoxische doses van verschillende stoffen, als ook kortdurende experimenten 
tonen aan dat een verandering van de D-glucaarzuurconcentratie in de urine 
beschouwd kan worden als een algemene aanwijzing voor blootstelling aan 
xenobiotica. Deze konklusie wordt bevestigd door de resultaten uit enige oriën-
terende onderzoekingen bij werknemers in de chemische industrie, die werden 
getest op hun D-glucaarzuurgehalte in de urine. 
Grote verschillen werden gevonden tussen, enerzijds het effect van een aan-
tal xenobiotica op de D-glucaarzuuruitscheiding en anderzijds hun invloed op 
de aktiviteiten van enige enzymen, betrokken bij de omzetting van exogene 
stoffen. Op basis van deze verschillen werd gekonkludeerd dat de D-glucaar-
zuuruitscheiding in de urine niet zonder meer een maat is voor de farmacon-
metabole kapaciteit van de lever. 
Verder werd aangetoond dat in geval van kortdurende behandeling, een sti-
mulering van het D-glucuronzuursysteem onafhankelijk verloopt van een in-
duktie van UDPGdehydrogenase. De resultaten doen sterk vermoeden dat een 
stimulering van het D-glucuronzuursysteem het gevolg is van een verhoogde 
concentratie van UDPG in de levercel, die op haar beurt weer veroorzaakt 
wordt door een remming van de glycogeensynthese. 
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STELLINGEN 
I 
Verandering van de D-glucaarzuuruitscheiding in de urine kan worden 
beschouwd als een indicator voor belasting met lichaamsvreemde stof­
fen, echter niet als een betrouwbare index voor de kapaciteit van de le­
ver om lichaamsvreemde stoffen te metabohseren 
Dit proefschrift 
II 
Het is bekend dat de kapaciteit van de neonatus om farmaca te metabo­
hseren geringer is dan die van de volwassene Aangezien de meeste ge­
neesmiddelen de placenta passeren en kunnen accumuleren in foetaal 
weefsel, dient men Ьц toediening van geneesmiddelen aan vrouwen vlak 
voor het einde van de zwangerschap rekening te houden met de gevaren, 
verbonden aan een langdurige werking van deze farmacologisch aktieve 
stoffen in de pasgeborene 
Hormg, M G , Butler С M , Nowlin, J en Hill, R,M Life Sei 16 
651 (1975) 
III 
Stoffen met alkylerende eigenschappen die kunnen leiden tot de vor­
ming van covalente bindingen met het erfelijk materiaal in de cel, die­
nen in principe een MAC (maximaal aanvaardbare concentratie) waar­
de te hebben die gelijk is aan nul 

IV 
De ontwikkeling van een mercaptuurzuurtest als methode om blootstel­
ling aan potentieel alkylerende verbindingen te onderkennen, biedt goe­
de perspektieven 
Boyland, L , in Handbook of experimental pharmacology (Lds 
Brodic & Gillette), XXVIII/2, ρ 584, Springer Verlag, Berlin-
Heidclbcrg-Ncw York (1971) 
V 
Op grond van de resultaten van Bischoff et al , waaruit blijkt dat 
UDPglucose als zodanig met door de cel wordt opgenomen, is het zeer 
twijfelachtig of de door Okohcsanyi en Scremin gevonden toename van 
de UDPglucuronyltransferase-aktiviteit, na intraperitoneale toediening 
van UDPglucose aan ratten, een direkt effekt is van UDPglucose 
Bischoff, 1 , Licrsch, M , Kepplcr D en Decker, Κ , ¡loppe-
Sevier's/ Physiol them 351 729(1970) 
Okohcsanyi, L en Scremin, S, bnzyme 14 366 (1972/73) 
VI 
Voor de bestudering van biochemische regulatiemechanismen is toepas-
sing van geïsoleerde levercellen te verkie/en boven het gebruik van le-
vercoupes 
Ross, В D , Hems, R en Krebs, H A , Biochem J 102, 942 
(1967) 
Krebs, H Λ ,Aâv bnzymeRegul S, 335 (1970) 
Krebs, H A , Cornell, N W , Lund, Ρ en Hems, R , in Regulation 
ot hepatic metabolism (Eds Lundquist & Tygstrup), ρ 726, 
Munksgaard, Copenhagen (1974) 
VII 
Gezien het feit dat de teruggang in de werkgelegenheid voor een belang­
rijk deel een struktureel karakter draagt, is het raad¿aam om binnen het 
kader van het onderwijs meer aandacht te schenken aan de problema-
tiek samenhangende met een hierdoor toenemende vrije tijd 
Nijmegen, 25 juni 1975 W R F. NOTTEN 



